Document:

Exhibit 4.2

 

SECURITIES
PURCHASE AGREEMENT

 

This
Securities Purchase Agreement (this “Agreement”) is dated as of February 27, 2020, between Lianluo Smart Limited,
a British Virgin Islands company (the “Company”), and each purchaser identified on the signature pages hereto
(each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

 

WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to (i) an effective registration statement under
the Securities Act of 1933, as amended (the “Securities Act”) as to the Shares and (ii) an exemption from the
registration requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and/or Regulation D thereunder
as to the Warrants, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires
to purchase from the Company, securities of the Company as more fully described in this Agreement.

 

NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration
the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

 

ARTICLE
I.

DEFINITIONS

 

1.1
Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following
terms have the meanings set forth in this Section 1.1:

 

“Acquiring
Person” shall have the meaning ascribed to such term in Section 4.5.

 

“Action”
shall have the meaning ascribed to such term in Section 3.1(j).

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person as such terms are used in and construed under Rule 405 under the Securities Act.

 

“Board
of Directors” means the board of directors of the Company.

 

“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action
to close.

 

“Closing”
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.

 

“Closing
Date” means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable
parties thereto, and all conditions precedent to (i) the Purchasers’ obligations to pay the Subscription Amount and (ii)
the Company’s obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later
than the second (2nd) Trading Day following the date hereof.

 

     

     

    

 

“Commission”
means the United States Securities and Exchange Commission.

 

“Common
Shares” means the Class A Common Shares of the Company, par value US$0.002731 per share, and any other class of securities
into which such securities may hereafter be reclassified or changed.

 

“Common
Share Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Shares, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive,
Common Shares.

 

“Company
Counsel” means Bevilacqua PLLC, with offices located at 1050 Connecticut Avenue, NW, Suite 500, Washington, DC 20036.

 

“Disclosure
Schedules” means the Disclosure Schedules of the Company delivered concurrently herewith.

 

“EGS”
means Ellenoff Grossman & Schole LLP, with offices located at 1345 Avenue of the Americas, New York, New York 10105-0302.

 

“Evaluation
Date” shall have the meaning ascribed to such term in Section 3.1(s).

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Exempt
Issuance” means the issuance of (a) Common Shares or options to employees, officers or directors of the Company pursuant
to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors
or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the
Company, provided, however, such issuance shall not exceed 5% of the Common Shares issued and outstanding as of the date hereof,
(b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable
or exchangeable for or convertible into Common Shares issued and outstanding on the date of this Agreement, provided that such
securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the
exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations)
or to extend the term of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions approved
by a majority of the disinterested directors of the Company, provided that such securities are issued as “restricted securities”
(as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself
or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company
and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction
in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business
is investing in securities.

 

    2

     

    

 

“FCPA”
means the Foreign Corrupt Practices Act of 1977, as amended.

 

“GAAP”
shall have the meaning ascribed to such term in Section 3.1(h).

 

“Indebtedness”
shall have the meaning ascribed to such term in Section 3.1(aa).

 

“Intellectual
Property Rights” shall have the meaning ascribed to such term in Section 3.1(p).

 

“Legend
Removal Date” shall have the meaning ascribed to such term in Section 4.1(c).

 

“Liens”
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

“Lock-Up
Agreements” means the written agreement, in the form of Exhibit B attached hereto, addressed to the Placement
Agent by each of the Company’s directors, officers and major shareholder.

 

“Material
Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).

 

“Material
Permits” shall have the meaning ascribed to such term in Section 3.1(n).

 

“Per
Share Purchase Price” equals US$0.70, subject to adjustment for reverse and forward stock splits, stock dividends, stock
combinations and other similar transactions of the Common Shares that occur after the date of this Agreement.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Placement
Agent” means Maxim Group LLC.

 

“Placement
Agency Agreement” means the Placement Agency Agreement dated as of February 27, 2020 by and between the Company and
the Placement Agent.

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial
proceeding, such as a deposition), whether commenced or threatened.

 

“Prospectus”
means the final prospectus filed for the Registration Statement.

 

“Prospectus
Supplement” means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with
the Commission and delivered by the Company to each Purchaser at the Closing.

 

    3

     

    

 

“Purchaser
Party” shall have the meaning ascribed to such term in Section 4.8.

 

“Registration
Statement” means the effective registration statement with Commission file No. 333-227817 which registers the sale of
the Shares to the Purchasers.

 

“Required
Approvals” shall have the meaning ascribed to such term in Section 3.1(e).

 

“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.

 

“Rule
424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.

 

“SEC
Reports” shall have the meaning ascribed to such term in Section 3.1(h).

 

“Securities”
means, collectively, the Shares, the Warrants and the Warrant Shares.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Shares”
means the Class A Common Shares issued or issuable to each Purchaser pursuant to this Agreement.

 

“Short
Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall
not be deemed to include locating and/or borrowing Common Shares). 

 

“Subscription
Amount” means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as
specified below such Purchaser’s name on the signature page of this Agreement and next to the heading “Subscription
Amount,” in United States dollars and in immediately available funds.

 

“Subsidiary”
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company
formed or acquired after the date hereof.

 

“Trading
Day” means a day on which the principal Trading Market is open for trading.

 

“Trading
Market” means any of the following markets or exchanges on which the Common Shares are listed or quoted for trading
on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
the New York Stock Exchange (or any successors to any of the foregoing).

 

    4

     

    

 

“Transaction
Documents” means this Agreement, the Warrants, the Placement Agency Agreement, the Lock-Up Agreements, all exhibits
and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated
hereunder.

 

“Transfer
Agent” means Computershare Limited, the current transfer agent of the Company, with a mailing address of Meidinger Tower,
462 S. 4th Street, Louisville, KY 40202, and any successor transfer agent of the Company.

 

“Variable
Rate Transaction” shall have the meaning ascribed to such term in Section 4.12(b).

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares are then
listed or quoted on a Trading Market, the daily volume weighted average price of the Common Shares for such date (or the nearest
preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a
Trading Market, the volume weighted average price of the Common Shares for such date (or the nearest preceding date) on OTCQB
or OTCQX as applicable, (c) if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for
the Common Shares are then reported on the Pink Sheet Open Market published by OTC Markets Group, Inc. (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per Common Share so reported, or (d) in
all other cases, the fair market value of a Common Share as determined by an independent appraiser selected in good faith by the
Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.

 

“Warrants”
means, the Common Shares purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof,
which Warrants shall be exercisable immediately and have a term of exercise equal to five years and six months from the issuance
date in the form of Exhibit A attached hereto.

 

“Warrant
Shares” means the Common Shares issuable upon exercise of the Warrants.

 

    5

     

    

 

ARTICLE
II.

PURCHASE AND SALE

 

2.1
Closing. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell,
and the Purchasers, severally and not jointly, agree to purchase, up to an aggregate of US$3,430,000 of Shares and Warrants. Each
Purchaser’s Subscription Amount as set forth on the signature page hereto executed by such Purchaser shall be made available
for “Delivery Versus Payment” settlement with the Company or its designee. The Company shall deliver to each Purchaser
its respective Shares and Warrants as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver
the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth
in Sections 2.2 and 2.3, the Closing shall occur at the offices of EGS or such other location as the parties shall mutually agree.
Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via “Delivery Versus Payment”
(“DVP”) (i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers’
names and addresses and released by the Transfer Agent directly to the account(s) at the Placement Agent identified by each Purchaser;
upon receipt of such Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser,
and payment therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company). Notwithstanding
anything to the contrary hereunder, to the extent that a Purchaser determines, in its sole discretion, that such Purchaser (together
with such Purchaser’s Affiliates, and any Person acting as a group together with such purchaser or any of such Holder’s Affiliates)
would beneficially own in excess of 9.99% of the number of Common Shares outstanding immediately prior to giving effect to the
issuance of the Securities on the Closing Date (“Beneficial Ownership Maximum”), such Purchaser may elect to receive
only the Beneficial Ownership Maximum at the Closing with the balance of any share purchased hereunder, if any, held in abeyance
for such Purchaser and issued immediately following the Closing provided in no event shall such Purchaser’s beneficial ownership
ever exceed the Beneficial Ownership Maximum.

 

2.2
Deliveries.

 

(a)
On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser and the Placement Agent
the following. Other than with respect to item 2.2 (a)(v) below, these deliverables shall be reasonably acceptable to each Purchaser:

 

(i)
this Agreement duly executed by the Company;

 

(ii)
legal opinions of (w) Company Counsel with respect to U.S. laws and securities matters; (x) Beijing Zaixian Law Firm with respect
to PRC laws (including, without limitation, a negative assurance letter or statement); and (y) Conyers Dill & Pearman with
respect to British Virgin Islands laws, in a form satisfactory to EGS and the Placement Agent;

 

(iii)
a duly executed and delivered intellectual property certificate from Ping Chen, Chief Executive Officer of the Company, in customary
form reasonably satisfactory to EGS and the Placement Agent;

 

(iv)
a duly executed and delivered regulatory certificate from Ping Chen, Chief Executive Officer of the Company, in form and substance
reasonably acceptable to EGS and Placement Agent;

 

(v)
a cold comfort letter, addressed to the Placement Agent in form and substance reasonably satisfactory in all material respects
from Centurion ZD CPA & Co.;

 

(vi)
the Lock-Up Agreements;

 

    6

     

    

 

(vii)
a duly executed and delivered Officer’s Certificate, in customary form reasonably satisfactory to EGS and the Placement
Agent;

 

(viii)
[Reserved]

 

(ix)
the duly executed and delivered certificate of its Chief Financial Officer with respect to certain financial
information dated as of the Closing Date, and in form and substance satisfactory to EGS and the Placement
Agent;

 

(x)
subject to the last sentence of Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer
Agent to deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (“DWAC”)
Shares equal to such Purchaser’s Subscription Amount divided by the Per Share Purchase Price, registered in the name of
such Purchaser;

 

(xi)
a Warrant registered in the name of such Purchaser to purchase up to a number of Common Shares equal to 100% of such Purchaser’s
Shares, with an exercise price equal to US$0.70, subject to adjustment therein; and

 

(xii)
the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).

 

(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:

 

(i)
this Agreement duly executed by such Purchaser; and

 

(ii)
such Purchaser’s Subscription Amount, which shall be made available for “Delivery Versus Payment” settlement
with the Company or its designee.

 

2.3
Closing Conditions.

 

(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:

 

(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material
Adverse Effect, in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein
(unless as of a specific date therein in which case they shall be accurate as of such date);

 

(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have
been performed; and

 

(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.

 

    7

     

    

 

(b)
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions
being met:

 

(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material
Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained
herein (unless as of a specific date therein in which case they shall be accurate as of such date);

 

(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been
performed;

 

(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;

 

(iv)
there shall have been no Material Adverse Effect with respect to the Company since the date hereof;

 

(v)
each of the Lock-Up Agreements shall remain in full force and effect; and

 

(vi)
from the date hereof to the Closing Date, trading in the Common Shares shall not have been suspended by the Commission or the
Company’s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported
by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose
trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the
United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or
other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial
market which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the
Securities at the Closing.

 

ARTICLE
III.

REPRESENTATIONS AND WARRANTIES

 

3.1
Representations and Warranties of the Company. Except as set forth in the Disclosure Schedules, which Disclosure Schedules
shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained
in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties
to each Purchaser:

 

(a)
Subsidiaries. All of the direct and indirect subsidiaries of the Company and their respective jurisdictions of incorporation
are set forth on Schedule 3.1(a). The Company owns, directly or indirectly, all of the capital stock or other equity interests
of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary
are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.

 

    8

     

    

 

(b)
Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite
power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the
Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation,
bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business
and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted
or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as
the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity
or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business,
prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse
effect on the Company’s ability to perform in any material respect on a timely basis its obligations under any Transaction
Document (any of (i), (ii) or (iii), a “Material Adverse Effect”) and no Proceeding has been instituted in
any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

 

(c)
Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company
and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action
on the part of the Company and no further action is required by the Company, the Board of Directors or the Company’s shareholders
in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction
Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in
accordance with the terms hereof and thereof, will constitute the valid and binding obligations of the Company enforceable against
the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
liquidation, possessory liens, rights of set off, merger, consolidation, reorganization, moratorium and other laws of general
application affecting enforcement of creditors’ rights generally as well as applicable international sanctions, (ii) as
limited by laws relating to the statutory limitation of the time within which proceedings may be brought or availability of specific
performance, injunctive relief or other equitable remedies, (iii) insofar as indemnification and contribution provisions may be
limited by applicable law and (iv) that such obligations (a) may not be given effect to by a British Virgin Islands court if and
to the extent they constitute the payment of an amount which is in the nature of a penalty and (b) may not be given effect by
a British Virgin Islands court to the extent that they are to be performed in a jurisdiction outside the British Virgin Islands
and such performance would be illegal under the laws of that jurisdiction.

 

    9

     

    

 

(d)
No Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents
to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby
and thereby do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate
or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default
(or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon
any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration
or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing
a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which
any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court
or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of clause (ii), such
as could not have or reasonably be expected to result in a Material Adverse Effect.

 

(e)
Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of,
give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority
or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other
than: (i) the filings required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus
Supplement, (iii) application(s) to each applicable Trading Market for the listing of the Shares and Warrant Shares for trading
thereon in the time and manner required thereby, and (iv) the filing of Form D with the Commission and such filings as are required
to be made under applicable state securities laws (collectively, the “Required Approvals”).

 

    10

     

    

 

(f)
Issuance of the Securities; Registration. The Securities are duly authorized and, when issued and paid for in accordance
with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all
Liens imposed by the Company. The Warrant Shares, when issued in accordance with the terms of the Warrants, will be validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized
unissued shares the maximum number of Common Shares issuable pursuant to this Agreement and the Warrants. The Company has prepared
and filed the Registration Statement in conformity with the requirements of the Securities Act, which became effective on November
8, 2018 (the “Effective Date”), including the Prospectus, and such amendments and supplements thereto as may
have been required to the date of this Agreement. The Registration Statement is effective under the Securities Act and no stop
order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus
has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the Company,
are threatened by the Commission. The Company, if required by the rules and regulations of the Commission, shall file the Prospectus
with the Commission pursuant to Rule 424(b). At the time the Registration Statement and any amendments thereto became effective,
at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed and will
conform in all material respects to the requirements of the Securities Act and did not and will not contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein
not misleading; and the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement
thereto was issued and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities
Act and did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company was
at the time of the filing of the Registration Statement eligible to use Form F-3. The Company is eligible to use Form F-3 under
the Securities Act and it meets the transaction requirements with respect to the aggregate market value of securities being sold
pursuant to this offering and during the twelve (12) months prior to this offering, as set forth in General Instruction I.B.5
of Form F-3.

 

(g)
Capitalization. The capitalization of the Company as of the date hereof is as set forth on Schedule 3.1(g), which
Schedule 3.1(g) shall also include the number of Common Shares owned beneficially, and of record, by Affiliates of the
Company as of the date hereof. The Company has not issued any shares since its most recently filed periodic report under the Exchange
Act, other than pursuant to the exercise of employee stock options under the Company’s stock option plans, the issuance
of Common Shares to employees pursuant to the Company’s employee stock purchase plans and pursuant to the conversion and/or
exercise of Common Share Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange
Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in
the transactions contemplated by the Transaction Documents. Except as set forth on Schedule 3.1(g) and as a result of the
purchase and sale of the Securities, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments
of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable
for, or giving any Person any right to subscribe for or acquire, any Common Shares or the capital stock of any Subsidiary, or
contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue
additional Common Shares or Common Share Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities
will not obligate the Company or any Subsidiary to issue Common Shares or other securities to any Person (other than the Purchasers)
and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price
under any of such securities. Except as set forth on Schedule 3.1(g), there are no outstanding securities or instruments of the
Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary.
The Company does not have any stock appreciation rights or “phantom stock” plans or agreements or any similar plan
or agreement. All of the outstanding shares of the Company are duly authorized, validly issued, fully paid and nonassessable,
have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation
of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any
shareholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders
agreements, voting agreements or other similar agreements with respect to the Company’s shares to which the Company is a
party or, to the knowledge of the Company, between or among any of the Company’s shareholders.

 

    11

     

    

 

(h)
SEC Reports; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents
required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d)
thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation
to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein,
together with the Prospectus and the Prospectus Supplement, being collectively referred to herein as the “SEC Reports”)
on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration
of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of
the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement
of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. Additionally, any further documents so
filed and incorporated by reference in the Prospectus and Prospectus Supplement, when such documents are filed with the Commission,
will conform in all material respects to the requirements of the Exchange Act and the applicable rules and regulations, as applicable,
and will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
therein, in light of the circumstances under which they were made not misleading. No post-effective amendment to the Registration
Statement reflecting any facts or events arising after the date thereof which represent, individually or in the aggregate, a fundamental
change in the information set forth therein is required to be filed with the Commission. The Company has never been an issuer
subject to Rule 144(i) under the Securities Act. As of their respective dates, the financial statements of the Company included
in the SEC Reports complied in all material respects with applicable accounting requirements and the rules and regulations of
the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance
with United States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company
and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods
then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. The agreements and
documents described in the Registration Statement, the Prospectus, the Prospectus Supplement, and the SEC Reports conform in all
material aspects to the descriptions thereof contained therein and there are no agreements or other documents required by the
Securities Act and the rules and regulations thereunder to be described in the Registration Statement, the Prospectus, the Prospectus
Supplement or the SEC Reports or to be filed with the Commission as exhibits to the Registration Statement, that have not been
so described or filed. Each agreement or other instrument (however characterized or described) to which the Company is a party
or by which it is or may be bound or affected and (i) that is referred to in the Registration Statement, the Prospectus,
the Prospectus Supplement or the SEC Reports, or (ii) is material to the Company’s business (each, a “Material
Agreement”), has been duly authorized and validly executed by the Company, is in full force and effect in all material
respects and is enforceable against the Company and, to the Company’s knowledge, the other parties thereto, in accordance
with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws
affecting creditors’ rights generally, (y) as enforceability of any indemnification or contribution provision may be
limited under the federal and state securities laws, and (z) that the remedy of specific performance and injunctive and other
forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding
therefore may be brought. No Material Agreement has been assigned by the Company, and neither the Company nor, to the best of
the Company’s knowledge, any other party is in default thereunder and, to the best of the Company’s knowledge, no
event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder that has
had or that could reasonably be expected to result in a Material Adverse Effect. To the best of the Company’s knowledge,
performance by the Company of the material provisions of the Material Agreements will not result in a violation of any existing
applicable law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign, having jurisdiction
over the Company or any of its assets or businesses, including, without limitation, those relating to environmental laws and regulations.
The other financial and statistical information included in the SEC Reports present fairly, in all material respects, the information
included therein and have been prepared on a basis consistent with that of the financial statements that are included in the SEC
Reports and the books and records of the respective entities presented therein.

 

    12

     

    

 

(i)
Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial statements
included within the SEC Reports, except as set forth on Schedule 3.1(i), (i) there has been no event, occurrence or development,
including changes generally affecting the medical devices industry, that has had or that could reasonably be expected to result
in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade
payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not
required to be reflected in the Company’s financial statements pursuant to GAAP or disclosed in filings made with the Commission,
(iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution
of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of
its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on Schedule 3.1(i),
no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or
exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets
or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this
representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this
representation is made. Other than as set forth on Schedule 3.1(i), the Company has not: (i) issued any securities or incurred
any liability or obligation, direct or contingent, for borrowed money; or (ii) declared or paid any dividend or made any other
distribution on or in respect of its capital stock.

 

(j)
Litigation. Except as set forth on Schedule 3.1(j), there has not been, and to the knowledge of the Company, there
is not pending or contemplated, any action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the
knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before
or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an “Action”) which (i) adversely affects or challenges the legality, validity or enforceability
of any of the Transaction Documents or the Securities, (ii) could, if there were an unfavorable decision, have or reasonably be
expected to result in a Material Adverse Effect or (iii) are not expected to have a material Adverse Effect. Neither the Company
nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation
of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the
knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any
current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the
effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.

 

(k)
Labor Relations. Except as set forth on Schedule 3.1(k), no labor dispute exists or, to the knowledge of the Company, is
imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse
Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s
relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective
bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. To
the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation
of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition
agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment
of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of
the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws
and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except
where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.

 

    13

     

    

 

(l)
Compliance. Except as set forth on Schedule 3.1(l), neither the Company nor any Subsidiary: (i) is in default under
or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result
in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it
is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument
to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived),
(ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or
has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product
quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result
in a Material Adverse Effect.

 

(m)
Environmental Laws. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws
relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land
surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals,
pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”)
into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport
or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments,
licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder
(“Environmental Laws”); (ii) have received all permits licenses or other approvals required of them under applicable
Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of any such
permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected to
have, individually or in the aggregate, a Material Adverse Effect.

 

(n)
Regulatory Permits. The Company and the Subsidiaries possess all certificates, authorizations, approvals, orders, licenses
and permits issued by the appropriate federal, state, local or foreign regulatory authorities, including, without limitations,
those administered by the U.S. Food and Drug Administration (“FDA”) of the U.S. Department of Health and Human
Services, the Centers for Medicare & Medicaid Services (“CMA”), or by any foreign, federal, state or local
governmental or regulatory authority performing functions similar to those performed by the FDA or CMS necessary to conduct their
respective businesses as described in the SEC Reports, including but not limited to, China Food and Drug Administration, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (each, a “Material
Permit”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation
or modification of any Material Permit. The disclosures in the Registration Statement concerning the effects of federal, state,
local and all foreign regulation on the Company’s business as currently contemplated are correct in all material respects.

 

    14

     

    

 

(o)
Title to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned
by them and good and marketable title in all personal property owned by them that is material to the business of the Company and
the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such
property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries
and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance
with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under
lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company
and the Subsidiaries are in compliance which the failure to so have could have a Material Adverse Effect.

 

(p)
Intellectual Property. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications,
trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual
property rights and similar rights necessary or required for use in connection with their respective businesses as described in
the SEC Reports and which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual
Property Rights”). Schedule 3.1(p) sets forth all of the Intellectual Property Rights that the Company and its Subsidiaries
own or have the rights to use. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial
statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property
Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material
Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing
infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable
security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure
to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

(q)
Intentionally omitted.

 

(r)
Transactions With Affiliates and Employees. Except as set forth on Schedule 3.1(r), none of the officers or directors
of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary
is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and
directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing
for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise
requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which
any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member
or partner, in each case in excess of US$120,000 other than for (i) payment of salary or consulting fees for services rendered,
(ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements
under any stock option plan of the Company.

 

    15

     

    

 

(s)
Sarbanes-Oxley; Internal Accounting Controls. Except as disclosed in the SEC Reports, the Company and the Subsidiaries
have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company
and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed
by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within
the time periods specified in the Commission’s rules and forms. The Company’s certifying officers have evaluated the
effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered
by the most recently filed periodic report under the Exchange Act (such date, the “Evaluation Date”). The Company
presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the
effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation
Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act)
of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal
control over financial reporting of the Company and its Subsidiaries.

 

(t)
Certain Fees. Other than the compensation payable to the Placement Agent pursuant to the terms of the Placement Agency
Agreement and as set forth in the Prospectus Supplement relating to the placement of the Securities, no brokerage or finder’s
fees or commissions are or will be payable by the Company or any Subsidiary or Affiliate of the Company to any broker, financial
advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated
by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims made
by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions
contemplated by the Transaction Documents.

 

(u)
Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940,
as amended. The Company shall conduct its business in a manner so that it will not become an “investment company”
subject to registration under the Investment Company Act of 1940, as amended.

 

    16

     

    

 

(v)
Registration Rights. Except as provided in this Agreement, no Person has any right to cause the Company or any Subsidiary
to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.

 

(w)
Listing and Maintenance Requirements. The Common Shares are registered pursuant to Section 12(b) or 12(g) of the Exchange
Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the
registration of the Common Shares under the Exchange Act nor has the Company received any notification that the Commission is
contemplating terminating such registration. Except as set forth on Schedule 3.1(w), the Company has not, in the 12 months
preceding the date hereof, received notice from any Trading Market on which the Common Shares are or have been listed or quoted
to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company
shall take all commercially reasonable efforts to regain compliance with the listing or maintenance requirements of such Trading
Market as soon as practicable, but in any event within 180 days of the date of the deficiency letters dated September 11, 2019
and January 2, 2020, respectively, as described in Schedule 3.1(w). The Common Shares are currently eligible for electronic transfer
through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the
fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.

 

(x)
Application of Takeover Protections. The Company and the Board of Directors have taken all necessary action, if any, in
order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under
a rights agreement) or other similar anti-takeover provision under the Company’s certificate of incorporation (or similar
charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result
of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including
without limitation as a result of the Company’s issuance of the Securities and the Purchasers’ ownership of the Securities.

 

    17

     

    

 

(y)
Disclosure. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or
their agents or counsel with any information that it believes constitutes or might constitute material, non-public information
which is not otherwise disclosed in the Prospectus Supplement. The Company understands and confirms that the Purchasers will rely
on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or
on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions
contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue
statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the
light of the circumstances under which they were made, not misleading. There are no documents required to be filed with the
Commission in connection with the transaction contemplated hereby that (x) have not been filed as required pursuant to the Securities
Act or (y) will not be filed within the requisite time period. There are no contracts or other documents required to be described
in the Preliminary Prospectus or Prospectus, or to be filed as exhibits or schedules to the Registration Statement, which have
not been described or filed as required.  The press releases disseminated by the Company during the twelve months preceding
the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which
they were made and when made, not misleading. The statistical and market-related data included in the Prospectus and Prospectus
Supplement, if any, are based on or derived from sources that the Company reasonably and in good faith believes are reliable and
accurate or represent the Company’s good faith estimates that are made on the basis of data derived from such sources. The
Company has obtained all consents required for the inclusion of such statistical and market-related data in the Prospectus and
Prospectus Supplement. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of
the Exchange Act) contained in the Prospectus or Prospectus Supplement has been made or reaffirmed without a reasonable basis
or has been disclosed other than in good faith. The Company acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.

 

(z)
No Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section
3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly,
made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this
offering of the Securities to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would
require the registration of the Warrants or Warrant Shares under the Securities Act, or (ii) any applicable shareholder approval
provisions of any Trading Market on which any of the securities of the Company are listed or designated.

 

(aa)
Solvency. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the
receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company’s
assets exceeds the amount that will be required to be paid on or in respect of the Company’s existing debts and other liabilities
(including known contingent liabilities) as they mature, (ii) the Company’s assets do not constitute unreasonably small
capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account
the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements
and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would
receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient
to pay all amounts on or in respect of its liabilities when such amounts are required to be paid. The Company does not intend
to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable
on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe that it will
file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the
Closing Date. For the avoidance of doubt, such reorganization does not include the Company’s mergers, acquisitions or other
strategic transactions which are not for the primary purpose of avoiding bankruptcy. Schedule 3.1(aa) sets forth as of
the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company
or any Subsidiary has commitments. For the purposes of this Agreement, “Indebtedness” means (x) any liabilities
for borrowed money or amounts owed in excess of US$50,000 (other than trade accounts payable incurred in the ordinary course of
business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or
not the same are or should be reflected in the Company’s consolidated balance sheet (or the notes thereto), except guaranties
by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business;
and (z) the present value of any lease payments in excess of US$50,000 due under leases required to be capitalized in accordance
with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.

 

    18

     

    

 

(bb)
Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result
in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and
local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which
it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined
to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the
payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There
are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of
the Company or of any Subsidiary know of no basis for any such claim. The provisions for taxes payable, if any, shown on the financial
statements filed with or as part of the Registration Statement, Prospectus and Prospectus Supplement are sufficient for all accrued
and unpaid taxes, whether or not disputed, and for all periods to and including the dates of such consolidated financial statements.  The
term “taxes” mean all federal, state, local, foreign, and other net income, gross income, gross receipts, sales, use,
ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, excise, severance,
stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees, assessments, or charges of any kind
whatsoever, together with any interest and any penalties, additions to tax, or additional amounts with respect thereto.  The
term “returns” means all returns, declarations, reports, statements, and other documents required to be filed in respect
to taxes.

 

(cc)
Foreign Corrupt Practices. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary,
any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for
unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii)
made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties
or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made
by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material
respect any provision of FCPA. The Company has taken commercially reasonable steps to ensure that its accounting controls and
procedures are designed to cause the Company to comply in all material respects with the FCPA.

 

    19

     

    

 

(dd)
Accountants. The Company’s independent registered public accounting firms are Centurion ZD CPA & Co. for the
year ended December 31, 2018 and BDO China Shu Lun Pan Certified Public Accountants LLP for the year ended December 31, 2019,
both of which are registered public accounting firms as required by the Exchange Act. To the knowledge and belief of the Company,
BDO China Shu Lun Pan Certified Public Accountants LLP shall express its opinion with respect to the financial statements to be
included in the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2019.

 

(ee)
Acknowledgment Regarding Purchasers’ Purchase of Securities. The Company acknowledges and agrees that each of the
Purchasers is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the
transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary
of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby
and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction
Documents and the transactions contemplated thereby is merely incidental to the Purchasers’ purchase of the Securities.
The Company further represents to each Purchaser that the Company’s decision to enter into this Agreement and the other
Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company
and its representatives.

 

(ff)
Acknowledgment Regarding Purchaser’s Trading Activity. Anything in this
Agreement or elsewhere herein to the contrary notwithstanding (except for Sections 3.2(f) and 4.14 hereof), it is understood and
acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed,
to desist from purchasing or selling, long and/or short, securities of the Company, or “derivative” securities based
on securities issued by the Company or to hold the Securities for any specified term; (ii) past or future open market or other
transactions by any Purchaser, specifically including, without limitation, Short Sales or “derivative” transactions,
before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company’s
publicly-traded securities; (iii) any Purchaser, and counter-parties in “derivative” transactions to which any such
Purchaser is a party, directly or indirectly, presently may have a “short” position in the Common Shares,
and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm’s length counter-party
in any “derivative” transaction. The Company further understands and acknowledges that (y) one or more Purchasers
may engage in hedging activities at various times during the period that the Securities are outstanding, including, without limitation,
during the periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, if applicable,
and (z) such hedging activities (if any) could reduce the value of the existing stockholders’ equity interests in the Company
at and after the time that the hedging activities are being conducted.  The Company acknowledges that such aforementioned
hedging activities do not constitute a breach of any of the Transaction Documents.

 

    20

     

    

 

(gg)
Regulation M Compliance.  The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly
or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of
the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation
for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting
another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid
to the Company’s placement agent in connection with the placement of the Securities.

 

(hh)
Stock Option Plans. Each stock option granted by the Company under the Company’s stock option plan was granted (i)
in accordance with the terms of the Company’s stock option plan and (ii) with an exercise price at least equal to the fair
market value of the Common Shares on the date such stock option would be considered granted under GAAP and applicable law. No
stock option granted under the Company’s stock option plan has been backdated. The Company has not knowingly granted, and
there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate
the grant of stock options with, the release or other public announcement of material information regarding the Company or its
Subsidiaries or their financial results or prospects.

 

(ii)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered
by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).

 

(jj)
U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding corporation
within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser’s
request.

 

(kk)
Bank Holding Company Act. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding
Company Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve
System (the “Federal Reserve”). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls,
directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent
(25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.
Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

 

    21

     

    

 

(ll)
Money Laundering. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance
with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of
1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money
Laundering Laws”), and no Action or Proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of
the Company or any Subsidiary, threatened.

 

(mm)
D&O Questionnaires.  To the Company’s knowledge, all information contained in the questionnaires most
recently completed by each of the Company’s directors and officers and beneficial owner of 5% or more of the Common Shares
or Common Share Equivalents is true and correct in all respects and the Company has not become aware of any information which
would cause the information disclosed in such questionnaires become inaccurate and incorrect.

 

(nn)
FINRA Affiliation.  No officer, director or any beneficial owner of 5% or more of the Company’s Common
Shares or Common Share Equivalents has any direct or indirect affiliation or association with any FINRA member (as determined
in accordance with the rules and regulations of FINRA) that is participating in the Offering. Except for securities purchased
on the open market, no Company Affiliate is an owner of stock or other securities of any member of FINRA.  No Company
Affiliate has made a subordinated loan to any member of FINRA.  No proceeds from the sale of the Securities (excluding
compensation as disclosed in the Prospectus Supplement to the Placement Agent) will be paid to any FINRA member, any persons associated
with a FINRA member or an affiliate of a FINRA member. Except as disclosed in the Registration Statement, Prospectus
and Prospectus Supplement and except for securities issued to the Placement Agent as disclosed in the Prospectus Supplement,
no person to whom securities of the Company have been privately issued within the 180-day period prior to the initial filing date
of the Prospectus Supplement is a FINRA member, is a person associated with a FINRA member or is an affiliate of a FINRA member.  No FINRA
member participating in the offering has a conflict of interest with the Company. For this purpose, a “conflict of interest”
exists when a FINRA member, the parent or affiliate of a FINRA member or any person associated with a FINRA member in the aggregate
beneficially own 5% or more of the Company’s outstanding subordinated debt or common equity, or 5% or more of the Company’s
preferred equity. “FINRA member participating in the offering” includes any associated person of a FINRA member that
is participating in the offering, any member of such associated person’s immediate family and any affiliate of a FINRA member
that is participating in the offering.  “Any person associated with a FINRA member” means (1) a natural
person who is registered or has applied for registration under the rules of FINRA and (2) a sole proprietor, partner, officer,
director, or branch manager of a FINRA member, or other natural person occupying a similar status or performing similar functions,
or a natural person engaged in the investment banking or securities business who is directly or indirectly controlling or controlled
by a FINRA member.  When used in this Section 3.1(mm) the term “affiliate of a FINRA member” or “affiliated
with a FINRA member” means an entity that controls, is controlled by or is under common control with a FINRA member. The
Company will advise the EGS if it learns that any officer, director or owner of 5% or more of the Company’s outstanding
Common Shares or Common Share Equivalents is or becomes an affiliate or associated person of a FINRA member firm.

 

    22

     

    

 

(oo) Officers’ Certificate.  Any certificate signed by any duly authorized officer of the Company and delivered to the
Purchasers shall be deemed a representation and warranty by the Company to the Purchasers as to the matters covered
thereby.

 

(pp)
Board of Directors.  The qualifications of the persons serving as board members and the overall composition of
the Board of Directors comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder applicable to the Company
and the rules of the Trading Market. At least one member of the Board of Directors qualifies as a “financial expert”
as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder and the rules of the Trading
Market.  In addition, at least a majority of the persons serving on the Board of Directors qualify as “independent”
as defined under the rules of the Trading Market.

 

(qq)
ERISA.  The Company is not a party to an “employee benefit plan,” as defined in Section 3(3) of the
Employee Retirement Income Security Act of 1974, as amended (“ERISA”), which: (i) is subject to any provision of ERISA
and (ii) is or was at any time maintained, administered or contributed to by the Company or any of its ERISA Affiliates (as defined
hereafter). These plans are referred to collectively herein as the “Employee Plans.” An “ERISA Affiliate”
of any person or entity means any other person or entity which, together with that person or entity, could be treated as a single
employer under Section 414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended (the “Code”). Each
Employee Plan has been maintained in material compliance with its terms and the requirements of applicable law. No Employee Plan
is subject to Title IV of ERISA. The Registration Statement, Prospectus and the Prospectus Supplement identify each employment,
severance or other similar agreement, arrangement or policy and each material plan or arrangement required to be disclosed pursuant
to the Rules and Regulations providing for insurance coverage (including any self-insured arrangements), workers’ compensation,
disability benefits, severance benefits, supplemental unemployment benefits, vacation benefits or retirement benefits, or deferred
compensation, profit-sharing, bonuses, stock options, stock appreciation rights or other forms of incentive compensation, or post-retirement
insurance, compensation or benefits, which: (i) is not an Employee Plan; (ii) is entered into, maintained or contributed to, as
the case may be, by the Company or any of its ERISA Affiliates; and (iii) covers any officer or director or former officer or
director of the Company or any of its ERISA Affiliates. These agreements, arrangements, policies or plans are referred to collectively
as “Benefit Arrangements.” Each Benefit Arrangement has been maintained in material compliance with its terms and
with the requirements of applicable law. There is no liability in respect of post-retirement health and medical benefits for retired
employees of the Company or any of its ERISA Affiliates, other than medical benefits required to be continued under applicable
law. No “prohibited transaction” (as defined in either Section 406 of ERISA or Section 4975 of the Code) has occurred
with respect to any Employee Plan; and each Employee Plan that is intended to be qualified under Section 401(a) of the Code is
so qualified, and nothing has occurred, whether by action or by failure to act, which could cause the loss of such qualification.

 

    23

     

    

 

(rr)
No Immunity. None of the Company or its Subsidiaries or any of their respective properties, assets or revenues has any
right of immunity, under the laws of the State of Nevada, the State of New York, from any legal action, suit or proceeding, the
giving of any relief in any such legal action, suit or proceeding, set-off or counterclaim, the jurisdiction of any Nevada, New
York or United States federal court, service of process, attachment upon or prior to judgment, or attachment in aid of execution
of judgment, or execution of a judgment, or other legal process or proceeding for the giving of any relief or for the enforcement
of a judgment, in any such court, with respect to its obligations, liabilities or any other matter under or arising out of or
in connection with this Agreement and the Transaction Documents; and, to the extent that the Company or any of its Subsidiaries
or any of their respective properties, assets or revenues may have or may hereafter become entitled to any such right of immunity
in any such court in which proceedings may at any time be commenced, each of the Company and its Subsidiaries waives or will waive
such right to the extent permitted by law and has consented to such relief and enforcement as provided in this Agreement.

 

(ss)
Lock-Up Agreements. Each of the Company’s directors, officers and major shareholder has signed a Lock-Up Agreement, addressed
to the Placement Agent.

 

(tt)
Private Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2,
no registration under the Securities Act is required for the offer and sale of the Warrant or the Warrant Shares by the Company
to the Purchasers as contemplated hereby.

 

(uu)
No General Solicitation. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of
the Warrants or Warrant Shares by any form of general solicitation or general advertising. The Company has offered the Warrants
and Warrant Shares for sale only to the Purchasers and certain other “accredited investors” within the meaning of
Rule 501 under the Securities Act.

 

(vv)
No Disqualification Events. With respect to the Warrants and Warrant Shares to be offered and sold hereunder in reliance
on Rule 506 under the Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive
officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company’s
outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule
405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an “Issuer Covered
Person”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii)
under the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule
506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a
Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e),
and has furnished to the Purchasers a copy of any disclosures provided thereunder.

 

(ww)
Other Covered Persons. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered
Person) that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with
the sale of any Securities.

 

    24

     

    

 

(xx)
Notice of Disqualification Events. The Company will notify the Purchasers in writing, prior to the Closing Date of (i)
any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably
be expected to become a Disqualification Event relating to any Issuer Covered Person, in each case of which it is aware.

 

(yy)
Projections. The projections included in SEC Reports, including but not limited to any statement with respect to projected
revenues, net margin and operating income (the “Projections”), were prepared by the Company based on reasonable and
appropriate assumptions for projections of such kind and with respect to the Company, including, among other things, (i) the Company’s
anticipated future performance after the consummation of this offering, (ii) general business and economic conditions, (iii) competitive
forces and (iv) the actions of regulatory agencies and governmental bodies. The Projections are based upon an analysis of the
data available to the Company, after due inquiry, at the time of the Projections, and the Company believes the information contained
in the Projections is reasonably accurate. The Company expects that the Projections will be realized. The Projections were prepared
in accordance with standards for projections promulgated by the American Institute of Certified Public Accountants or with a view
to compliance with published guidelines of the Commission regarding projections or forecasts contained in Item 10(b) of Regulation
S-K.

 

3.2
Representations and Warranties of the Purchasers. Each Purchaser, for itself and for no other Purchaser, hereby represents
and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein,
in which case they shall be accurate as of such date):

 

(a)
Organization; Authority. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership,
limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the
Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction
Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized
by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser.
Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser
in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against
it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii)
as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)
insofar as indemnification and contribution provisions may be limited by applicable law.

 

    25

     

    

 

(b)
Understandings or Arrangements. Such Purchaser is acquiring the Securities as principal for its own account and has no
direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities
(this representation and warranty not limiting such Purchaser’s right to sell the Securities pursuant to the Registration
Statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities
hereunder in the ordinary course of its business. Such Purchaser understands that the Warrants and the Warrant Shares are “restricted
securities” and have not been registered under the Securities Act or any applicable state securities law and is acquiring
such Securities as principal for his, her or its own account and not with a view to or for distributing or reselling such Securities
or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing
any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect
arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation
of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser’s
right to sell such Securities pursuant to a registration statement or otherwise in compliance with applicable federal and state
securities laws).

 

(c)
Purchaser Status. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on
each date on which it exercises any Warrants, it will be either: (i) an “accredited investor” as defined in Rule 501(a)(1),
(a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified institutional buyer” as defined in
Rule 144A(a) under the Securities Act.

 

(d)
Experience of Such Purchaser. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk
of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.

 

(e)
Access to Information. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents
(including all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions
as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions
of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the
Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable
it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can
acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. 
Such Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided
such Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary or desired. 
Neither the Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality of the Securities
and the Placement Agent and any Affiliate may have acquired non-public information with respect to the Company which such Purchaser
agrees need not be provided to it.  In connection with the issuance of the Securities to such Purchaser, neither the Placement
Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.

 

    26

     

    

 

(f)
Certain Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, such Purchaser
has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed
any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time
that such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company
setting forth the material pricing terms of the transactions contemplated hereunder and ending immediately prior to the execution
hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of such Purchaser’s assets and the portfolio managers have no direct knowledge
of the investment decisions made by the portfolio managers managing other portions of such Purchaser’s assets, the representation
set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment
decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such
Purchaser’s representatives, including, without limitation, its officers, directors, partners, legal and other advisors,
employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection
with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance
of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating
or borrowing shares in order to effect Short Sales or similar transactions in the future.

 

(g)
General Solicitation. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice
or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television
or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.

 

The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such
Purchaser’s right to rely on the Company’s representations and warranties contained in this Agreement or any representations
and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection
with this Agreement or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance
of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating
or borrowing shares in order to effect Short Sales or similar transactions in the future.

 

    27

     

    

 

ARTICLE
IV.

OTHER AGREEMENTS OF THE PARTIES

 

4.1
Removal of Legends.

 

(a)
The Warrants and Warrant Shares may only be disposed of in compliance with state and federal securities laws. In connection with
any transfer of Warrants or Warrant Shares other than pursuant to an effective registration statement or Rule 144, to the Company
or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the
transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the
Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer
does not require registration of such transferred Warrants or Warrant Shares under the Securities Act.

 

(b)
The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Warrants or Warrant
Shares in the following form:

 

NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO,
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND
THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED
BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a)
UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

The
Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a
registered broker-dealer or grant a security interest in some or all of the Warrants or Warrant Shares to a financial institution
that is an “accredited investor” as defined in Rule 501(a) under the Securities Act and, if required under the terms
of such arrangement, such Purchaser may transfer pledged or secured Warrants or Warrant Shares to the pledgees or secured parties.
Such a pledge or transfer shall not require a legal opinion of legal counsel of the pledgee, secured party or pledger. The Board
of Directors may not refuse or delay the transfer unless: (a) the Purchaser has failed to pay an amount due in respect of such
securities; or (b) such refusal or delay is deemed necessary or advisable in the view of the Company or its legal counsel in order
to avoid violation of, or in order to ensure compliance with, any applicable corporate, securities and other laws and regulation;
provided, that in no event shall such refusal or delay be unreasonably withheld. Further, no notice shall be required of such
pledge. At the Purchaser’s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured
party of Warrants and Warrant Shares may reasonably request in connection with a pledge or transfer of the Warrants or Warrant
Shares.

 

    28

     

    

 

(c)
Certificates evidencing the Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof):
(i) while a registration statement covering the resale of such security is effective under the Securities Act, or (ii) following
any sale of such Warrant Shares pursuant to Rule 144 (assuming cashless exercise of the Warrants), or (iii) if such Warrant Shares
are eligible for sale under Rule 144 (assuming cashless exercise of the Warrants), or (iv) if such legend is not required under
applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the
Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or a Purchaser promptly if required
by the Transfer Agent to effect the removal of the legend hereunder, or if requested by such Purchaser; provided, however,
that if any such legal opinion relates to legend removal, or sale of Securities, pursuant to Rule 144, such opinion may be qualified
in the event that the Company then fails for any reason to satisfy the current public information requirement under Rule 144(c),
to the extent that Rule 144(c) is applicable. If all or any portion of a Warrant is exercised at a time when there is an effective
registration statement to cover the resale of the Warrant Shares, or if such Warrant Shares may be sold under Rule 144 (assuming
cashless exercise of the Warrants) or if such legend is not otherwise required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Warrant Shares shall
be issued free of all legends. The Company agrees that following such time as such legend is no longer required under this Section
4.1(c), the Company will, no later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined below) following the delivery by a Purchaser to the Company or the Transfer Agent of
a certificate representing Warrant Shares, as applicable, issued with a restrictive legend (such date, the “Legend Removal
Date”), deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from
all restrictive and other legends. The Company may not make any notation on its records or give instructions to the Transfer Agent
that enlarge the restrictions on transfer set forth in this Section 4. Warrant Shares subject to legend removal hereunder shall
be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser’s prime broker with the
Depository Trust Company System as directed by such Purchaser. As used herein, “Standard Settlement Period”
means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with
respect to the Common Shares as in effect on the date of delivery of a certificate representing Warrant Shares issued with a restrictive
legend.

 

    29

     

    

 

(d)
In addition to such Purchaser’s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial
liquidated damages and not as a penalty, for each US$1,000 of Warrant Shares (based on the VWAP of the Common Shares on the date
such securities are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c),
US$10 per Trading Day (increasing to US$20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for
each Trading Day after the Legend Removal Date until such certificate is delivered without a legend and (ii) if the Company fails
to (a) issue and deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the securities
so delivered to the Company by such Purchaser that is free from all restrictive and other legends and (b) if after the Legend
Removal Date such Purchaser purchases (in an open market transaction or otherwise) Common Shares to deliver in satisfaction of
a sale by such Purchaser of all or any portion of the number of Common Shares, or a sale of a number of Common Shares equal to
all or any portion of the number of Common Shares, that such Purchaser anticipated receiving from the Company without any restrictive
legend, then an amount equal to the excess of such Purchaser’s total purchase price (including brokerage commissions and
other out-of-pocket expenses, if any) for the Common Shares so purchased (including brokerage commissions and other out-of-pocket
expenses, if any) (the “Buy-In Price”) over the product of (A) such number of Warrant Shares that the
Company was required to deliver to such Purchaser by the Legend Removal Date multiplied by (B) the lowest closing sale price of
the Common Shares on any Trading Day during the period commencing on the date of the delivery by such Purchaser to the Company
of the applicable Warrant Shares (as the case may be) and ending on the date of such delivery and payment under this Section 4.1(d).

 

(e)
The Shares shall be issued free of legends.

 

4.2
Furnishing of Information.

 

(a)
Until the earlier of the time that (i) no Purchaser owns Securities or (ii) all of the Warrants have expired, the Company covenants
to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be
filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting
requirements of the Exchange Act.

 

(b)
At any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all
of the Warrant Shares (assuming cashless exercise) may be sold without the requirement for the Company to be in compliance with
Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason
to satisfy the current public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i)
or becomes an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a “Public
Information Failure”) then, in addition to such Purchaser’s other available remedies, the Company shall pay to
a Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability
to sell the Warrant Shares, an amount in cash equal to two percent (2.0%) of the aggregate Exercise Price of such Purchaser’s
Warrants on the day of a Public Information Failure and on every thirtieth (30th) day (pro rated for periods totaling
less than thirty days) thereafter until the earlier of (a) the date such Public Information Failure is cured and (b) such time
that such public information is no longer required  for the Purchasers to transfer the Warrant Shares pursuant to Rule 144. 
The payments to which a Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to herein as “Public
Information Failure Payments.”  Public Information Failure Payments shall be paid on the earlier of (i) the last
day of the calendar month during which such Public Information Failure Payments are incurred and (ii) the third (3rd)
Business Day after the event or failure giving rise to the Public Information Failure Payments is cured.  In the event the
Company fails to make Public Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear
interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser’s
right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies
available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.

 

    30

     

    

 

4.3
Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any
security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in
a manner that would require the registration under the Securities Act of the sale of the Warrants or Warrant Shares or that would
be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that
it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before
the closing of such subsequent transaction.

 

4.4
Securities Laws Disclosure; Publicity. The Company shall (a) by 9:30 a.m. (New York City time) on February 27, 2020, issue
a press release disclosing the material terms of the transactions contemplated hereby, and (b) file a Report of Foreign Private
Issuer on Form 6-K, including the Transaction Documents as exhibits thereto, with the Commission within the time required by the
Exchange Act. From and after the issuance of such press release, the Company represents to the Purchasers that it shall have publicly
disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or
any of their respective officers, directors, employees or agents in connection with the transactions contemplated by the Transaction
Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any and all
confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries
or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the Purchasers or
any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser shall consult with each other in issuing
any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall
issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect
to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the
Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case
the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding
the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any
filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except
(a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission and
(b) to the extent such disclosure is required by law or Trading Market or FINRA regulations, in which case the Company shall provide
the Purchasers with prior notice of such disclosure permitted under this clause (b).

 

4.5
Shareholder Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any other
Person, that any Purchaser is an “Acquiring Person” under any control share acquisition, business combination,
poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter
adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue
of receiving Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.

 

    31

     

    

 

4.6
Non-Public Information. Except with respect to the material terms and conditions of the transactions contemplated by the
Transaction Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor
any other Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes,
or the Company reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have
consented to the receipt of such information and agreed with the Company to keep such information confidential. The Company understands
and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.
To the extent that the Company delivers any material, non-public information to a Purchaser without such Purchaser’s consent,
the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of
its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates, or a duty to the Company, any
of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates not to trade on the basis
of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that
any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding
the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Report of
Foreign Private Issuer on Form 6-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing
covenant in effecting transactions in securities of the Company.

 

4.7
Use of Proceeds. Except as set forth on Schedule 4.7 attached hereto, the Company shall use the net proceeds from
the sale of the Securities hereunder for working capital and capital expenditure purposes and shall not use such proceeds: (a)
for the satisfaction of any portion of the Company’s debt (other than payment of trade payables in the ordinary course of
the Company’s business and prior practices), (b) for the redemption of any Common Shares or Common Share Equivalents, (c)
for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.

 

    32

     

    

 

4.8
Indemnification of Purchasers. Subject to the provisions of this Section 4.8, the Company will indemnify (to the fullest
extent permitted by applicable law) and hold each Purchaser and its directors, officers, shareholders, members, partners, employees
and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of
such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act
and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any
other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any
other title) of such controlling persons (each, a “Purchaser Party”) harmless from any and all losses, liabilities,
obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs
and reasonable attorneys’ fees and costs of investigation that any such Purchaser Party may suffer or incur as a result
of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this
Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or
any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party,
with respect to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material
breach of such Purchaser Party’s representations, warranties or covenants under the Transaction Documents or any agreements
or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or
federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross
negligence or willful misconduct) or (c) in connection with any registration statement of the Company providing for the resale
by the Purchasers of the Warrant Shares issued and issuable upon exercise of the Warrants, the Company will indemnify each Purchaser
Party, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs
(including, without limitation, reasonable attorneys’ fees) and expenses, as incurred, arising out of or relating to (i)
any untrue or alleged untrue statement of a material fact contained in such registration statement, any prospectus or any form
of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any
omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in
the case of any prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading,
except to the extent, but only to the extent, that such untrue statements or omissions are based solely upon information regarding
such Purchaser Party furnished in writing to the Company by such Purchaser Party expressly for use therein, or (ii) any violation
or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation
thereunder in connection therewith. If any action shall be brought against any Purchaser Party in respect of which indemnity may
be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall
have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any
Purchaser Party shall have the right to employ one separate counsel in any such action and participate in the defense thereof,
but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (x) the employment
thereof has been specifically authorized by the Company in writing, (y) the Company has failed after a reasonable period of time
to assume such defense and to employ counsel or (z) in such action there is, in the reasonable opinion of counsel, a material
conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the
Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will
not be liable to any Purchaser Party under this Agreement (1) for any settlement by a Purchaser Party effected without the Company’s
prior written consent, which shall not be unreasonably withheld or delayed; or (2) to the extent, but only to the extent that
a loss, claim, damage or liability is attributable to any Purchaser Party’s breach of any of the representations, warranties,
covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification
required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or
defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any
cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject
to pursuant to law.

 

    33

     

    

 

4.9
Reservation of Common Shares. As of the date hereof, the Company has reserved and the Company shall continue to reserve
and keep available at all times, free of preemptive rights, a sufficient number of Common Shares for the purpose of enabling the
Company to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.

 

4.10
Listing of Common Shares. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common
Shares on the Trading Market on which it is currently listed, and prior to the Closing, the Company shall have applied to list
or quote all of the Shares and Warrant Shares on such Trading Market and concurrently with the Closing, the Company shall have
not received any information indicating that the listing of such shares is or will be rejected. The Company further agrees, if
the Company applies to have the Common Shares traded on any other Trading Market, it will then include in such application all
of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and Warrant Shares
to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably
necessary to continue the listing and trading of its Common Shares on a Trading Market and will comply in all respects with the
Company’s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to
maintain the eligibility of the Common Shares for electronic transfer through the Depository Trust Company or another established
clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established
clearing corporation in connection with such electronic transfer.

 

4.11
Intentionally omitted.

 

4.12
Subsequent Equity Sales.

 

(a)
From the date hereof until 60 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any
agreement to issue or announce the issuance or proposed issuance of any Common Shares or Common Share Equivalents or file any
registration statement, or amendment or supplement thereto, with the Commission, other than a prospectus filed with the Commission
pursuant to Rule 424(b) in connection with this offering.

 

(b)
From the date hereof until such time as no Purchaser holds any of the Warrants, the Company shall be prohibited from effecting
or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Shares or Common Share
Equivalents (or a combination of units thereof) involving a Variable Rate Transaction. “Variable Rate Transaction”
means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable
or exercisable for, or include the right to receive additional Common Shares either (A) at a conversion price, exercise price
or exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the Common Shares
at any time after the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price
that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence
of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Shares
or (ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit, whereby
the Company may issue securities at a future determined price. Any Purchaser shall be entitled to obtain injunctive relief against
the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.

 

    34

     

    

 

(c)
Notwithstanding the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance, except that no Variable Rate
Transaction shall be an Exempt Issuance. Additionally, the Purchasers hereby waive any rights they may be entitled to pursuant
to Section 4.12 of those certain Securities Purchase Agreements dated February 12, 2020 and February 21, 2020, with respect to
the transactions contemplated by this Agreement.

 

4.13
Equal Treatment of Purchasers. No consideration (including any modification of any Transaction Document) shall be offered
or paid to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the
same consideration is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision
constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended
for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or
as a group with respect to the purchase, disposition or voting of Securities or otherwise.

 

4.14
Certain Transactions and Confidentiality. Each Purchaser, severally and not jointly with the other Purchasers, covenants
that neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or
sales, including Short Sales of any of the Company’s securities during the period commencing with the execution of this
Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to
the initial press release as described in Section 4.4.  Each Purchaser, severally and not jointly with the other Purchasers,
covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant
to the initial press release as described in Section 4.4, such Purchaser will maintain the confidentiality of the existence and
terms of this transaction and the information included in the Disclosure Schedules.  Notwithstanding the foregoing and notwithstanding
anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes
any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company
after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press
release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any
securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated
by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no
Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries
after the issuance of the initial press release as described in Section 4.4.  Notwithstanding the foregoing, in the case
of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such
Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio
managers managing other portions of such Purchaser’s assets, the covenant set forth above shall only apply with respect
to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered
by this Agreement.

 

    35

     

    

 

4.15
Capital Changes. Until the one year anniversary of the Closing Date, the Company shall not undertake a reverse or forward
stock split or reclassification of the Common Shares without the prior written consent of the Purchasers holding a majority in
interest of the Shares, unless a reverse split is required to maintain compliance with the minimum bid price requirements of the
Trading Market.

 

4.16
Exercise Procedures. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required
of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required
of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be
required in order to exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares
in accordance with the terms, conditions and time periods set forth in the Transaction Documents.

 

4.17
Form D; Blue Sky Filings. The Company agrees to timely file a Form D with respect to the Warrants and Warrant Shares as
required under Regulation D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such
action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Warrants
and Warrant Shares for, sale to the Purchasers at the Closing under applicable securities or “Blue Sky” laws of the
states of the United States, and shall provide evidence of such actions promptly upon request of any Purchaser.

 

4.18
Registration Statement. As soon as practicable (and in any event within 30 calendar days of the Closing Date), the Company
shall file a registration statement on Form F-3 (or other appropriate form if the Company is not then F-3 eligible) providing
for the resale by the Purchasers of the Warrant Shares issued and issuable upon exercise of the Warrants .  The Company shall
use commercially reasonable efforts to cause such registration to become effective within 181 days following the Closing Date
and to keep such registration statement effective at all times until no Purchaser owns any Warrants or Warrant Shares issuable
upon exercise thereof.

 

4.19
Lock-Up. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except
to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms.
If any officer or director that is a party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall
promptly use its best efforts to seek specific performance of the terms of such Lock-Up Agreement.

 

ARTICLE
V.

MISCELLANEOUS

 

5.1
Termination.  This Agreement may be terminated by any Purchaser, as to such Purchaser’s obligations hereunder
only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the
other parties, if the Closing has not been consummated on or before the fifth (5th) Trading Day following the date
hereof; provided, however, that no such termination will affect the right of any party to sue for any breach by
any other party (or parties).

 

    36

     

    

 

5.2
Fees and Expenses. At the Closing, the Company has agreed to reimburse the Placement Agent the non-accountable sum of US$60,000
for its legal fees and expenses. Except as expressly set forth in the Transaction Documents to the contrary, each party shall
pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by
such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall
pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter
delivered by the Company and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection
with the delivery of any Securities to the Purchasers.

 

5.3
Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus
Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede
all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been
merged into such documents, exhibits and schedules.

 

5.4
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication
is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages
attached hereto at or prior to 4:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission,
if such notice or communication is delivered via facsimile at the facsimile number or email attachment at the email address as
set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 4:30 p.m. (New York City time)
on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for
such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided
pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Report of Foreign Private Issuer on Form 6-K.

 

5.5
Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written
instrument signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the
Shares based on the initial Subscription Amounts hereunder or, in the case of a waiver, by the party against whom enforcement
of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely
impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall
be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition
or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise
of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations
of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent
of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser
and holder of Securities and the Company.

 

    37

     

    

 

5.6
Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed
to limit or affect any of the provisions hereof.

 

5.7
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written
consent of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any
Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound,
with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the “Purchasers.”

 

5.8
No Third-Party Beneficiaries. The Placement Agent shall be the third party beneficiary of the representations and warranties
of the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended
for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor
may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8, this Section 5.8 and/or
the Placement Agency Agreement.

 

5.9
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard
to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a
party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be
commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to
the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication
of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including
with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert
in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action
or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service
of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified
mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence
an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company
under Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable
attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action
or Proceeding.

 

    38

     

    

 

5.10
Survival. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.

 

5.11
Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other
party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by
facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and
binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if
such facsimile or “.pdf” signature page were an original thereof.

 

5.12
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein
shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use
their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result
as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention
of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any
of such that may be hereafter declared invalid, illegal, void or unenforceable.

 

5.13
Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under
a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then
such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant
notice, demand or election in whole or in part without prejudice to its future actions and rights; provided, however,
that in the case of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required to return any Common
Shares subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise
price paid to the Company for such shares and the restoration of such Purchaser’s right to acquire such shares pursuant
to such Purchaser’s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).

 

5.14
Replacement of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory
to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances
shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement
Securities and provide such indemnity as may be required and determined under the Company’s policy as set by the Board of
Directors.

 

    39

     

    

 

5.15
Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of
damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The
parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations
contained in the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any
such obligation the defense that a remedy at law would be adequate.

 

5.16
Payment Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction
Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement
or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered
from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other
Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of
action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be
revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

5.17
Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction
Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way
for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained
herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed
to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption
that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated
by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights including, without
limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary
for any other Purchaser to be joined as an additional party in any Proceeding for such purpose. Each Purchaser has been represented
by its own separate legal counsel in its review and negotiation of the Transaction Documents. For reasons of administrative convenience
only, each Purchaser and its respective counsel have chosen to communicate with the Company through EGS. EGS does not represent
any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers with the same
terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any
of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction
Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between
and among the Purchasers.

 

5.18
Liquidated Damages. The Company’s obligations to pay any partial liquidated damages or other amounts owing under
the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated
damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial
liquidated damages or other amounts are due and payable shall have been canceled.

 

    40

     

    

 

5.19
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next
succeeding Business Day.

 

5.20
Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity
to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to
be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments
thereto. In addition, each and every reference to share prices and Common Shares in any Transaction Document shall be subject
to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the
Common Shares that occur after the date of this Agreement.

 

5.21
WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER
PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. 

 

(Signature
Pages Follow)

 

    41

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.

 

	LIANLUO SMART
    LIMITED	 	 
	 	 	Address
    for Notice:
	By: 	          	 	 
	 	Name:	 	E-Mail:
	 	Title:	 	Fax:
	 	 	 	 
	With a copy to
    (which shall not constitute notice):	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE
PAGE FOR PURCHASER FOLLOWS]

 

    42

     

    

 

[PURCHASER
SIGNATURE PAGES TO LLIT SECURITIES PURCHASE AGREEMENT]

 

IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.

 

Name
of Purchaser: ________________________________________________________

 

Signature
of Authorized Signatory of Purchaser: _________________________________

 

Name
of Authorized Signatory: _______________________________________________

 

Title
of Authorized Signatory: ________________________________________________

 

Email
Address of Authorized Signatory:_________________________________________

 

Facsimile
Number of Authorized Signatory: __________________________________________

 

Address
for Notice to Purchaser:

 

Address
for Delivery of Warrants to Purchaser (if not same as address for notice):

 

DWAC
for Shares:

 

Subscription
Amount: US$_________________

 

Shares:
_________________

 

Warrant
Shares: __________________

 

EIN
Number: _______________________

 

☐
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed
to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations
of the Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded,
(ii) the Closing shall occur on the second (2nd) Trading Day following the date of this Agreement and (iii) any condition
to Closing contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company
or the above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be
a condition and shall instead be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such
agreement, instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date.

 

[SIGNATURE
PAGES CONTINUE]

 

 

43Exhibit 4.3

 

 

 

Newegg Inc.

17560 Rowland Street

City of Industry, CA 91748

Phone: (626) 271-9700

Fax: (626) 964-4626

 

October 23, 2020

 

Digital Grid (Hong Kong) Technology Co., Limited

Hangzhou Lianluo Interactive Technology Co., Ltd.

Hyperfinite Galaxy Holding Limited

10th Floor, Zhuzong Tower

No. 25 Mid Rd. of East 3rd Ring Road

Beijing, People’s Republic of China

Attention: Yingmei Yang

 

Fred Chang

1260 Dorothea Rd.

La Habra Heights, CA 90631

 

Lianluo Smart Limited (to be renamed Newegg
Commerce, Inc. at the Closing)

Room 611, 6th Floor

BeiKong Technology Building

No. 10 Baifuquan Road, Changping District

Beijing 102200, People’s Republic of China

 

Ladies and Gentlemen:

 

Reference is made herein to that certain Stockholders
Agreement dated March 30, 2017 (the “Stockholders Agreement”) by and among Newegg Inc., a Delaware corporation
(“Newegg”), the Newegg Stockholders (as defined therein), and Digital Grid (Hong Kong) Technology Co., Limited,
a company incorporated under the laws of Hong Kong (“Liaison”). Capitalized terms used but not defined herein
shall have the respective terms assigned thereto in the Stockholders Agreement.

 

Newegg, Lianluo Smart Limited, a business
company incorporated under the laws of the British Virgin Islands (“LLIT”), and Lightning Delaware Sub, Inc.,
a Delaware corporation (“Merger Sub”) have entered into that certain Agreement and Plan of Merger dated of even
date herewith (the “Merger Agreement”) pursuant to which Merger Sub will merge with and into Newegg (the “Merger”)
and Newegg will become a wholly-owned subsidiary of LLIT. The stockholders of Newegg will receive Class A common shares of LLIT
(which will become known as common shares upon completion of the Merger) as consideration for the Merger.

 

     

     

    

 

In connection with the transactions contemplated
by the Merger Agreement, including the Merger, the undersigned acknowledge and agree as follows:

 

1. Assignment to and Assumption by LLIT.
Effective at the Closing (as defined in the Merger Agreement), Newegg hereby assigns to LLIT, and LLIT hereby assumes, all of the
rights and obligations of Newegg under the Stockholders Agreement without further action by any of the parties hereto. For purposes
of complying with the terms of the Stockholders Agreement, any reference to Newegg set forth in such provisions shall be replaced
with LLIT and LLIT shall have all of the rights of, and the obligation to fulfill all of the obligations of, Newegg thereunder.

 

2. Application of Stockholders Agreement
to LLIT Common Shares. All references in the Stockholders Agreement to “Company Stock” or similar references are
hereby revised to be read as references to the Class A common shares of LLIT (which will become known as common shares upon completion
of the Merger).

 

3. Joinder. Hangzhou Lianluo Interactive
Technology Co., Ltd., a corporation incorporated in the Peoples’ Republic of
China, and Hyperfinite Galaxy Holding
Limited each agree to become a party to, be bound by the obligations of, and receive the benefits of, a Liaison party and a Principal
Stockholder as defined in and pursuant to the Stockholders Agreement, as amended from time to time thereafter, effective as of
the Closing.

 

4. Amendment and Restatement of Stockholders
Agreement. Effective immediately after the Closing and after giving effect to this letter agreement, the Stockholders Agreement
shall be amended and restated in its entirety and replaced with the Amended and Restated Shareholders Agreement attached hereto
as Exhibit A (the “A&R SHA”), which amendment and restatement shall occur immediately after the Closing
without further action by any of the parties hereto or thereto. The undersigned include, for the avoidance of doubt, Newegg (and
LLIT as successor in interest to Newegg), the Minority Representative and Liaison, which are the parties required under Section
6.11 of the Stockholders Agreement to effect such amendment and restatement and to give effect to the A&R SHA. The undersigned
represent and warrant that no other parties have a right to consent to such amendment and restatement.

 

5. Governing Law. This letter agreement
shall be governed by, and construed in accordance with, the Laws of the State of Delaware, regardless of the Laws that might otherwise
govern under applicable principles of conflicts of Laws thereof.

 

6. Counterparts. This letter agreement
may be executed in two or more counterparts, each of which shall be deemed to be an original and all of which together shall be
deemed to constitute one and the same agreement. This Agreement may be executed by facsimile or electronic transmission in portable
document format (.pdf), each of which shall be deemed an original.

 

	 	Sincerely,
	 	 	 
	 	NEWEGG INC.
	 	 	 
	 	By: 	 
	 	Name:	 
	 	Title:	 

 

    2

     

    

 

Acknowledged and Agreed:

 

	Lianluo Smart Limited (to be renamed 

Newegg Commerce, Inc. at the Closing)	 
	 	 	 
	By: 	                	 
	Name:	 	 
	Title:	 	 
	 	 	 
	Digital Grid (Hong Kong) Technology Co., Limited	 
	 	 	 
	By: 	 	 
	Name:	 	 
	Title:	 	 
	 	 	 
	Hangzhou Lianluo Interactive Technology Co., Ltd.	 
	 	 	 
	By: 	 	 
	Name:	 	 
	Title:	 	 
	 	 	 
	Hyperfinite Galaxy Holding Limited	 
	 	 	 
	By: 	 	 
	Name:	 	 
	Title:	 	 
	 	 	 
	 	 
	Fred Chang, as Minority Representative	 

 

    3

     

    

 

EXHIBIT A

 

     

     

    

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NEWEGG COMMERCE, INC.

 

AMENDED AND RESTATED

SHAREHOLDERS AGREEMENT

 

[●], 202[●]1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

		1	Note
                                         to Draft: Insert date of the Closing under the Merger Agreement.

 

     

     

    

 

TABLE OF CONTENTS

  

	 	 	Page
	 	 	 
	Article I. RESTRICTIONS ON TRANSFERS	2
	Section 1.01	Resale of Shares.	2
	Section 1.02	Pre-Emptive Rights.	2
	Section 1.03	Right of First Refusal	3
	Section 1.04	Void Assignment	5
	Section 1.05	Cooperation	5
	Section 1.06	Expenses	5
	Article II. LIQUIDATION; VOLUNTARY TERMINATION	5
	Article III. LOCKUP	5
	Section 3.01	“Market Stand-off” Agreement	5
	Article IV. INDEMNIFICATION; LIMITATION OF LIABILITY	6
	Section 4.01	Indemnification; Limitation of Liability	6
	Section 4.02	D&O Insurance	7
	Article V. GENERAL PROVISIONS	7
	Section 5.01	Confidentiality	7
	Section 5.02	Successors and Assigns	8
	Section 5.03	Specific Performance	8
	Section 5.04	Governing Law.	9
	Section 5.05	Waiver of Jury Trial	9
	Section 5.06	Interpretation	9
	Section 5.07	Notices	10
	Section 5.08	Reorganizations	11
	Section 5.09	Counterparts	12
	Section 5.10	Severability	12
	Section 5.11	Amendment and Waiver	12
	Section 5.12	Tax Withholding	12
	Section 5.13	Entire Agreement	12
	Section 5.14	Legends	13
	Article VI. DEFINITIONS	13

 

    - i -

     

    

 

NEWEGG COMMERCE, INC.

 

AMENDED AND RESTATED

SHAREHOLDERS AGREEMENT

 

This Amended and Restated Shareholders Agreement, dated as
of [●], 202[●] (this “Agreement”), is made by and among (i) Newegg Commerce, Inc., a business company
incorporated under the laws of the British Virgin Islands (the “Company”), as assignee of Newegg, Inc., a Delaware
corporation (“Newegg Delaware”), (ii) the Persons whose names appear on the signature pages hereto (collectively,
the “Newegg Shareholders”), and (iii) Digital Grid (Hong Kong) Technology Co., Limited, a company incorporated
under the laws of Hong Kong (“Digital Grid”), Hangzhou Lianluo Interactive Technology Co., Ltd., a corporation incorporated in the Peoples’ Republic of
China, and Hyperfinite Galaxy Holding Limited, (collectively, the parties
in this clause (iii), “Liaison” and, together with the Newegg Shareholders, the “Principal Shareholders”).
Each of the parties hereto is sometimes referred to individually as a “Party” and collectively as the “Parties”
in this Agreement.

 

RECITALS

 

WHEREAS, Newegg Delaware,
Digital Grid, and the Newegg Shareholders entered into that certain Stockholders Agreement on March 30, 2017 (the “Original
Agreement”);

 

WHEREAS, Newegg Delaware,
the Company (under its former name of Lianluo Smart Limited), and Lightning Delaware Sub, Inc., a Delaware corporation (“Merger
Sub”) entered into that certain Agreement and Plan of Merger dated October 23, 2020 (the “Merger Agreement”),
pursuant to which, among other things, Merger Sub merged with and into Newegg Delaware (the “Merger”), with
Newegg Delaware surviving as a wholly-owned Subsidiary of the Company; and

 

WHEREAS, as a condition
to the closing of the transactions contemplated by the Merger Agreement, including the Merger, the Original Agreement must be amended
and restated and replaced in its entirety by this Agreement.

 

NOW THEREFORE, in consideration
of the mutual covenants, conditions and agreements set forth herein and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Parties intending to be legally bound agree as follows:

 

    - 1 -

     

    

 

Article I.

RESTRICTIONS ON TRANSFERS

 

Section 1.01
Resale of Shares.

 

(a)
General Restriction. The Principal Shareholders shall, and shall cause each of its Affiliates to, not Transfer all or any
portion of Company Shares without first complying with the provisions of this ‎Article I and applicable Law.

 

(b)
Affiliate Transfers. Notwithstanding ‎Section 1.01 or ‎Section 1.03, a Principal Shareholder and its Affiliates
may Transfer Company Shares to an Affiliate (an “Affiliate Transferee”) so long as such Affiliate Transferee
executes a joinder to this Agreement in the form attached as Exhibit A (a “Joinder”) hereto agreeing
to be bound by the provisions of this Agreement which bind such Principal Shareholder as if such Affiliate Transferee were such
Principal Shareholder for purposes of this Agreement.

 

(c)
Permitted Transfers. Each of the Principal Shareholders may Transfer all or any portion of its Company Shares to a Permitted
Transferee without approval of the Board only in compliance with this ‎Article I and only if such Permitted Transferee
executes a Joinder agreeing to be bound by the provisions of this Agreement which bind such Principal Shareholder and such other
documents and instruments as the Board may reasonably request as necessary or appropriate to confirm such Permitted Transferee
as a stockholder in the Company.

 

(d)
Transferrable Rights and Obligations. Upon a Transfer in accordance with the terms of this Agreement by any Principal Shareholder
of a portion or all of its Company Shares, the Permitted Transferee shall (i) be bound by the obligations of the Transferring
Principal Shareholder hereunder and (ii) shall have such rights of the Transferring Principal Shareholder under this Agreement
as the Principal Shareholder shall assign in its sole discretion.

 

Section 1.02
Pre-Emptive Rights.

 

(a)
In the event that the Company intends to issue any Company Shares or other Equity Interests (including securities that are convertible
into or exchangeable for Company Shares or other Equity Interests) after the date hereof, other than any Excluded Issuance or in
connection with a Public Offering (the “New Securities”), the Company shall give written notice (a “Preemption
Notice”) thereof to the Principal Shareholders, which shall, as set forth below, provide each Principal Shareholder the
right to subscribe for its Pro Rata Share of the New Securities.

 

(b)
Each Preemption Notice (i) shall set forth the price (or formula by which the price will be determined, which may refer to a future
contingent event) and terms on which the Company proposes to issue the New Securities, together with a calculation of such Principal
Shareholder’s Pro Rata Share of the New Securities (the “Preemption Terms”), and (ii) offer to issue to
each Principal Shareholder up to such Pro Rata Share of the New Securities on the Preemption Terms, which offer must remain open
until at least the close of business on the 15th Business Day following the date on which the Principal Shareholder receives or
is deemed (pursuant to ‎Section 5.07) to receive the Preemption Notice (the “Preemption Election Period”).
Each Principal Shareholder exercising its preemptive rights must, within the Preemption Election Period, advise the Company in
writing (the “Preemption Exercise Notice”) whether it is exercising its rights (in whole or in part) hereunder
and deliver payment in full for the New Securities it elects to purchase. If a Principal Shareholder fails to deliver a Preemption
Exercise Notice, together with payment for the New Securities, within the Preemption Election Period, then such Principal Shareholder
shall be deemed to have waived its purchase rights under this ‎Section 1.02 in connection with such offering of New Securities
(and, for the avoidance of doubt, this shall not operate as a waiver with respect to any future offerings of New Securities).

 

    - 2 -

     

    

 

(c)
In the event any Principal Shareholder fails to give the Company a Preemption Exercise Notice within the Preemption Election Period,
or elects to purchase fewer than all of its Pro Rata Share of the New Securities, then, the Company shall give written notice of
any such unsubscribed New Securities to any Principal Shareholder who has elected to purchase all of its Pro Rata Share of the
New Securities, and each such Principal Shareholder shall have the right, by giving written notice to the Company within 2 Business
Days of receiving or being deemed (pursuant to ‎Section 5.07) to have received such written notice from the Company, to
purchase its Pro Rata Share of such unsubscribed New Securities on the Preemption Terms, and such right shall continue to apply
repeatedly and iteratively until all New Securities have been allocated to the Principal Shareholders or none of the Principal
Shareholders have elected to participate in such further purchase. If, at the end of such process, there are New Securities that
have not been subscribed for by the Principal Shareholders, the Company may, for a period of time not to exceed 60 days, sell such
unsubscribed New Securities, on the Preemption Terms, to a Third Party Purchaser. If, however, at the end of such 60-day period,
the Company has not consummated a sale of any of such unsubscribed New Securities, the Company shall no longer be permitted to
sell such New Securities without again complying with this ‎Section 1.02. 

 

(d) Notwithstanding any provision herein
to the contrary, any issuance of Equity Interest (other than an Excluded Issuance) by any Subsidiary of the Company other than
to the Company or a wholly owned Subsidiary of the Company shall be deemed an issuance by the Company of its Equity Interests to
which the preemptive rights under this ‎Section 1.02 shall apply, mutatis mutandis.

 

Section 1.03
Right of First Refusal.

 

(a)
In the event that any Principal Shareholder or any of its Affiliates (a “Transferring Shareholder”) receives
a bona fide offer from one or more Persons other than an Affiliate Transferee (each, a “Third Party Purchaser”)
to acquire any or all of its or its Affiliates’ Company Shares, and such Transferring Shareholder desires to Transfer any
or all of its Company Shares (the “ROFR Shares”) to such Third Party Purchaser pursuant to such bona fide offer
(a “ROFR Sale”), then (i) the Company shall have the right (a “ROFR Right”), but
not the obligation, to elect to purchase all (and not less than all) of the ROFR Shares proposed to be Transferred to the Third
Party Purchaser, at the same price, and on the same terms and conditions offered by the Third Party Purchaser (the “ROFR
Terms”), (ii) in the event the Company does not deliver a ROFR Exercise Notice during the Company ROFR Exercise Period,
or delivers a ROFR Exercise Notice for less than all of the ROFR Shares, then each of the Principal Shareholders other than the
Transferring Shareholders (each, a “ROFR Shareholder”) shall have a ROFR Right to elect to purchase all (and
not less than all) of its Pro Rata Share of the ROFR Shares proposed to be Transferred to the Third Party Purchaser on the ROFR
Terms. In the event that a ROFR Sale is in exchange for non-cash consideration, then the ROFR Right shall be exercisable based
on the Fair Market Value of such non-cash consideration.

 

    - 3 -

     

    

 

(b)
The Transferring Shareholder shall notify the Company and each ROFR Shareholder in writing of any ROFR Right at least 60 days prior
to the date (the “ROFR Sale Date”) on which the Transferring Shareholder expects to consummate the ROFR Sale
(the “ROFR Notice”). The ROFR Notice shall set forth (i) a copy of the written bona fide offer, if any,
(ii) a copy of the stock purchase agreement, merger agreement or any other agreements entered or to be entered into with the Third
Party Purchaser with respect to the Transfer (if available), and if not available, a summary of the material terms and conditions
pertaining to the Transfer, (iii) the proposed amount and form of consideration and other material terms and conditions, and (iv) the
ROFR Sale Date.

 

(c)
The Company may exercise its ROFR Right by delivery of an irrevocable written notice (the “ROFR Exercise Notice”)
to the Transferring Shareholder and each ROFR Shareholder, within 30 days following receipt of the ROFR Notice (the “Company
ROFR Exercise Period”), accepting the Transfer of all (but not less than all) of the ROFR Shares on the ROFR Terms.

 

(d)
In the event the Company does not deliver a ROFR Exercise Notice during the Company ROFR Exercise Period, or delivers a ROFR Exercise
Notice for less than all of the ROFR Shares, then each ROFR Shareholder may exercise its ROFR Right by delivery of a ROFR Exercise
Notice to the Company and the Transferring Shareholder, within 30 days following the first to occur of (i) the expiration of the
Company ROFR Exercise Period or (ii) receipt of a ROFR Exercise Notice from the Company which relates to less than all of
the ROFR Shares (the “Shareholder ROFR Exercise Period” and, together with the Company ROFR Exercise Period,
the “ROFR Exercise Periods”), accepting the Transfer of all (but not less than all) of its Pro Rata Share of
the ROFR Shares on the ROFR Terms. Such ROFR Right shall continue to apply repeatedly and iteratively during the Shareholder ROFR
Exercise Period until the time when all ROFR Shares have been allocated to the ROFR Shareholders or when all of the ROFR Shareholders
have elected not to make further purchases of ROFR Shares.

 

(e)
If the Transferring Shareholder receives one or more ROFR Exercise Notices for all of the ROFR Shares prior to the end of the applicable
ROFR Exercise Period, then the Parties shall consummate the sale of the ROFR Shares on the ROFR Terms.

 

(f)
If the Transferring Shareholder does not receive ROFR Exercise Notices sufficient to sell all of the ROFR Shares within the applicable
ROFR Exercise Period, then all of the ROFR Exercise Notices shall be null and void, and the Transferring Shareholder may effect
the Transfer of all of the ROFR Shares to the same Third Party Purchaser identified in the ROFR Notice on the ROFR Terms on or
prior to the later of (i) the 60th day following the date of the expiration of the applicable ROFR Exercise Period and (ii) if
applicable, the 10th day following the receipt of all necessary governmental approvals, but in no event later than the 90th day
following the date of the expiration of the applicable ROFR Exercise Period. If the Transfer of the ROFR Shares is not consummated
within such time period, then any proposed Transfer by such Transferring Shareholder shall once again be subject to the terms and
conditions of this ‎Section 1.03.

 

    - 4 -

     

    

 

Section 1.04
Void Assignment. Any purported Transfer of any Equity Interests of the Company in contravention of this Agreement
shall be void and ineffectual and shall not bind or be recognized by the Company or any other Party, and the Company shall not
record such Transfer on its books or treat any purported transferee of such Equity Interests as the owner of such Equity Interests
for any purpose. In the event of any Transfer in contravention of this Agreement, the purported transferee shall have no right
to any profits, losses or distributions of the Company or any other rights of a Principal Shareholder.

 

Section 1.05
Cooperation. In the event of a potential sale by a Transferring Shareholder to a Third Party Purchaser pursuant
to the terms of ‎Section 1.03, the Directors and officers of the Company shall (i) permit such potential Third
Party Purchaser, after executing a reasonable confidentiality agreement in customary form, to conduct a due diligence review of
the Company and its business, operations, prospects, assets, liabilities, financial condition, and results of operations, and
(ii) make available the officers and technical personnel of the Company, during normal business hours, upon reasonable advance
notice and at such Transferring Shareholder’s sole cost and expense, for the purpose of making presentations to, and answering
questions from, such potential Third Party Purchaser.

 

Section 1.06
Expenses. Except as otherwise provided herein, each Principal Shareholder shall bear its own expenses incurred in
connection with this ‎Article I, and any Principal Shareholder effecting a Transfer pursuant to this ‎Article I
shall reimburse the Company for any expenses incurred by the Company in connection therewith.

 

Article II.

LIQUIDATION; VOLUNTARY TERMINATION

 

Section 2.01
This Agreement shall terminate automatically upon the complete liquidation of the Company, or otherwise with the written
consent of each Principal Shareholder; provided that such transaction is duly approved pursuant to, and complies with,
the other provisions of this Agreement and applicable Law.

 

Article III.

LOCKUP

 

Section 3.01
“Market Stand-off” Agreement.

 

(a)
Each of the Holders agrees not to directly or indirectly sell or otherwise Transfer or dispose of any Locked Up Securities
held by such Holder, if requested by the Company and an underwriter of Equity Interests of the Company, for a period not
longer than (A) the 180-day period following a Public Offering and (B) the 90-day period following any subsequent public
offering of Locked Up Securities declared effective under the Securities Act, in each case beginning on the effective date of
the registration statement of the Company filed under the Securities Act if, and to the extent, requested by the managing
underwriter or underwriters in the case of an underwritten public offering (which period may be extended upon the request of
the managing underwriter, to extent required by any rules of the Financial Industry Regulatory Authority, Inc.); provided that
if such offering includes a primary underwritten offering by the Company, all directors and executive officers of the Company
enter into similar agreements; and provided further that if such offering does not include a
primary underwritten offering by the Company, the Holders shall only be required to enter into such agreements if such Holder
is selling shares in connection with such offering.

 

    - 5 -

     

    

 

(b)
If requested by the underwriters, the Holders shall execute a separate agreement to the foregoing effect. The Company may impose
stop-transfer instructions with respect to the shares (or securities) subject to the foregoing restriction until the end of said
period. The provisions of this ‎Section 3.01 shall be binding upon any transferee who acquires Locked Up Securities.

 

Article IV.

INDEMNIFICATION; LIMITATION OF LIABILITY

 

Section 4.01
Indemnification; Limitation of Liability.

 

(a)
Indemnification. Except as limited by applicable Law or the amended and restated articles of association of the Company,
and subject to the provisions of this ‎Section 4.01, the Directors, and
the directors or managers of each Subsidiary thereof (each an “Indemnitee”), shall not be liable for, and shall
be indemnified and held harmless by the Company against, any losses, liabilities and reasonable expenses (including reasonable
attorneys’ fees) (each, a “Loss”), arising from proceedings in which such Indemnitee may be involved,
as a party or otherwise, by reason of he or she being a Director of the Company, or director or manager of any Subsidiary thereof,
or by reason of his or her involvement in the management of the affairs of the Company or its Subsidiaries, whether or not he or
she continues to be such at the time any such Loss is paid or incurred. Notwithstanding the foregoing, an Indemnitee shall not
be held harmless or indemnified under this ‎Section 4.01 for any Losses
arising out of the fraud, dishonesty, intentional misconduct, or knowing or reckless breach of Indemnitee’s obligations under
this Agreement, or bad faith of such Indemnitee. The rights of indemnification provided in this ‎Section 4.01
are in addition to any rights to which an Indemnitee may otherwise be entitled by contract or as a matter of Law. Without limiting
the foregoing, an Indemnitee shall be entitled to indemnification by the Company against reasonable expenses (as incurred), including
attorneys’ fees, incurred by the Indemnitee in connection with the defense of any action to which the Indemnitee may be made
a party (without regard to the success of such defense), to the fullest extent permitted under the provisions of applicable Law.

 

(b)
Payments Prior to Final Disposition. Except as limited by applicable Law or the amended and restated articles of association
of the Company, expenses incurred by an Indemnitee in defending any proceeding (except a proceeding by or in the right of the Company
or any Principal Shareholder against such Indemnitee) shall be paid by the Company in advance of the final disposition of the proceeding,
upon receipt of a written undertaking by or on behalf of such Indemnitee to repay such amount if such Indemnitee is determined
pursuant to this ‎Section 4.01 or adjudicated to be ineligible for indemnification.
This undertaking shall be an unlimited general obligation of the Indemnitee but does not need to be secured unless so determined
by the Board.

 

    - 6 -

     

    

 

(c)
Heirs and Representatives. The indemnification provided by this ‎Section 4.01
shall inure to the benefit of the heirs and personal representatives of each Indemnitee.

 

(d)
Officers and Agents. The Company may, at the direction of the Board, indemnify and advance expenses to any officer, employee
or agent of the Company or its Subsidiaries to the same extent and subject to the same conditions under which it may indemnify
and advance expenses under ‎Section 4.01(a)
and ‎Section 4.01(b).

 

(e)
Not Exclusive. The right to indemnification and the advancement and payment of expenses conferred in this ‎Section 4.01
shall not be exclusive of any other right that a Director or other Person indemnified pursuant to this ‎Section 4.01
may have or hereafter acquire under any Law or provision of this Agreement.

 

(f)
No Shareholder Personal Liability for Indemnification. Any indemnification pursuant to this ‎Section 4.01
shall be made only out of the assets of the Company and shall not cause any Principal Shareholder to incur any personal liability
or result in any liability of any Principal Shareholder to any third party.

 

Section 4.02
D&O Insurance. The Company shall purchase and maintain director and officer liability insurance on behalf of
any Person who is or was a Director or officer of the Company, or any director, officer or manager of any Subsidiary thereof,
against any liability asserted against such Person or incurred by such Person in any capacity identified in ‎Section 4.01
or arising out of such Person’s status as an Indemnitee, whether or not the Company would have the power to indemnify such
Person against that liability under ‎Section 4.01.

 

Article V.

 

GENERAL
PROVISIONS

 

Section 5.01
Confidentiality.

 

(a)
Each Party agrees and acknowledges that the Principal Shareholders may receive confidential, non-public information about the Company
and any of its Subsidiaries.

 

(b)
No Party shall disclose any information relating to the Company or any Subsidiary thereof (the “Confidential Information”)
without the prior written consent of the Board (which consent shall not be unreasonably conditioned, withheld or delayed); provided
that (i) Confidential Information may be disclosed if required by applicable Law, legal process or any stock exchange
or other self-regulatory organization (subject to the provisions of ‎Section 5.01(c)),
or in connection with the making or maintaining of any claim by such Party, arising under this Agreement or asserting or enforcing
any rights hereunder and (ii) each Party may disclose Confidential Information to its Representatives that are actively engaged
in the monitoring or oversight of such Party’s investment in the Company and its Subsidiaries, so long as (x) such Representatives
agree to keep such information confidential (or the Party directs such Representative to keep such information confidential, in
which case such Party shall be liable for any failure on the part of its Representatives to so keep such information confidential),
and (y) the sharing of such Confidential Information with such Representatives does not violate any applicable Law; provided,
further, that the Newegg Shareholders and Liaison, their respective Affiliates, and their respective Representatives shall be permitted
to disclose Confidential Information to financial institutions, investment bankers and prospective purchasers (who are bound by
a customary non-disclosure agreement approved by the Board) in connection with soliciting, marketing and effecting a permitted
Transfer of its Company Shares. The term “Confidential Information” does not include information that (A) is
or has become generally available to the public other than as a result of a direct or indirect disclosure by a Party or any of
its Representatives in breach of the provisions hereof or (B) was within the possession of a Party or any of its Representatives
from a source other than the Company prior to its being furnished to such Party by or on behalf of the Company; provided,
that in the case of (B) above, the source of such information was not known by such Party to be bound by a confidentiality
agreement with, or other contractual, legal or fiduciary obligation of confidentiality to, the Company with respect to such information.

 

    - 7 -

     

    

 

(c)
In the event that any Party is required by applicable Law, regulation, legal process or any stock exchange or other self-regulatory
organization, to disclose any of the Confidential Information, such Party shall promptly notify the Company in writing so that
the Company may seek a protective order or other appropriate remedy. Nothing herein shall be deemed to prevent any Party from honoring
a subpoena (or governmental order) that seeks discovery of the Confidential Information if (A) a motion for a protective order,
motion to quash and/or other motion filed to prevent the production or disclosure of the Confidential Information has been denied
or is not made in a timely manner; provided, however, that such Party shall disclose only that portion of the Confidential
Information which such Party’s outside legal counsel advises is required and that it exercise commercially reasonable efforts
to preserve the confidentiality of the remainder of the Confidential Information; or (B) the Company consents in writing to having
the Confidential Information produced or disclosed pursuant to the subpoena (or governmental order). In no event will any Party
or any of its Representatives oppose any action by the Company to obtain a protective order or other relief to prevent the disclosure
of the Confidential Information or to obtain reliable assurance that confidential treatment will be afforded the Confidential Information.
The Company shall promptly reimburse the Party for any reasonable costs and expenses (including fees and disbursements of counsel)
incurred in connection with any action that the Party may be required to take, or is requested by the Company to take, under this
‎Section 5.01. Notwithstanding any other provision of this Agreement, no prior
notice, consent or other action shall be required in respect of any disclosure of Confidential Information made to any banking,
financial, accounting, securities or similar supervisory authority exercising its routine supervisory or audit functions, provided that such disclosure is made in the ordinary course and is not specific to the Company.

 

Section 5.02
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the Parties and their respective
legal representatives, heirs, legatees, successors and permitted assigns.

 

Section 5.03
Specific Performance. Each Party, in addition to being entitled to exercise all rights provided herein or granted
by Law, including recovery of damages, shall be entitled to seek specific performance of the Party’s rights under this Agreement.
Each Party agrees that monetary damages may not be adequate compensation for any loss incurred by reason of a breach by the Party
of the provisions of this Agreement and each Party hereby agrees to waive the defense in any action for specific performance that
a remedy at Law would be adequate.

 

    - 8 -

     

    

 

Section 5.04
Governing Law.

 

(a) The
terms and conditions of this Agreement and the rights of the parties hereunder shall be governed by and construed in all respects
in accordance with the laws of the British Virgin Islands.

 

(b)
The Parties hereby irrevocably agree that the courts of the British Virgin Islands shall have exclusive jurisdiction in respect
of any dispute, suit, action, arbitration or proceedings (“Proceedings”) which may arise out of or in connection
with this Agreement. By execution and delivery of this Agreement, each Party irrevocably submits to the jurisdiction of the above
courts for itself and in respect of its property with respect to such action. The Parties irrevocably agree that the venue would
be proper in each of the above courts, and hereby waive any objection to Proceedings in the courts of the British Virgin Islands
on the grounds of venue or on the basis that the Proceedings have been brought in an inconvenient forum. Delivery of any process
required by any of the above courts in accordance with ‎Section 5.07 shall constitute
valid and lawful service of process against each Party, without necessity for services by any other means provided by applicable
Law.

 

Section 5.05
Waiver of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT
IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES
ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING
TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.

 

Section 5.06
Interpretation. The table of contents and headings of the Sections contained in this Agreement are solely for the
purpose of reference, are not part of the agreement of the Parties and shall not affect the meaning or interpretation of this
Agreement. Unless the context otherwise requires: (a) an accounting term not otherwise defined has the meaning assigned to
it in accordance with then-applicable GAAP; (b) “or” is not exclusive; (c) words in the singular include
the plural, and words in the plural include the singular; (d) provisions apply to successive events and transactions; (e) the
words “herein,” “hereof” and other words of similar import refer to this Agreement as a whole and not
to any particular Article, or other subdivision; (f) all references herein to Articles, Sections, Recitals, Exhibits, Appendixes,
Annexes, paragraphs, subparagraphs and clauses shall be deemed to be references to Articles, Sections, Recitals, paragraphs, subparagraphs
and clauses of, and Exhibits, Appendixes and Annexes to, this Agreement unless the context shall otherwise require; (g) the
words “include,” “includes” and “including” shall be deemed to be followed by the phrase “without
limitation”; (h) the word “extent” in the phrase “to the extent” shall mean the degree to which
a subject or other thing extends, and such phrase shall not mean simply “if”; (i) references to “$”
or “dollars” shall mean United States dollars; (j) the word “days” refers to calendar days unless Business
Days are expressly specified; (k) if any action under this Agreement is required to be done or taken on a day that is not a Business
Day, then such action shall be required to be done or taken not on such day but on the first succeeding Business Day thereafter;
(l) references from or through any date mean, unless otherwise specified, from and including or through and including, respectively;
(m) the words “writing,” “written” and other words of similar import refer to printing, typing and other
means of reproducing words (including electronic media) in a visible form; (n) this Agreement is to be construed without regard
to any presumption or rule requiring construction or interpretation against the Party drafting or causing any instrument to be
drafted; and (o) unless otherwise expressly provided herein, any agreement, instrument or statute defined or referred to herein
or in any agreement or instrument that is referred to herein means such agreement, instrument or statute as from time to time
amended, modified or supplemented, consolidated, replaced or rewritten, including (in the case of agreements or instruments) by
waiver or consent and (in the case of statutes) by succession of comparable successor statutes and references to all attachments
thereto and instruments incorporated therein.

 

    - 9 -

     

    

 

Section 5.07
Notices. All notices, requests, demands, waivers and other communications required or permitted to be given or made
under this Agreement shall be in writing and shall be deemed to have been duly given or made if (a) delivered personally,
(b) mailed by certified or registered mail with postage prepaid, (c) sent by next-Business Day or overnight mail or
delivery, or (d) sent by facsimile or email, provided that delivery of such facsimile or email is promptly confirmed,
as follows (or at such other address for a Party as shall be specified by like notice):

 

		(i)	if to the Company, to

 

17560 Rowland Street

City of Industry, CA 91748

	 	Attention:	Anthony Chow, Chief Executive Officer;
	 	 	Matt Strathman, General Counsel; and
	 	 	Robert Chang, Chief Financial Officer
	 	E-mail:	Anthony.K.Chow@Newegg.com;
	 	 	Matt.O.Strathman@Newegg.com; and
	 	 	Robert.Y.Chang@Newegg.com

 

with a copy (which shall not constitute notice) to:

 

Gibson, Dunn & Crutcher LLP

3161 Michelson Drive

Irvine, CA 92612

	 	Attention:	David C. Lee
	 	E-mail:	DLee@GibsonDunn.com

 

(ii) if to any Newegg Shareholder, to the
last address for such Newegg Shareholder in the Register of Members of the Company.

 

    - 10 -

     

    

 

		(iii)	if to any Liaison party, to

 

10th Floor, Zhuzong Tower

No. 25 Mid Rd. of East 3rd Ring Road

Beijing, People’s Republic of China

	 	Attention:	Yingmei Yang
	 	E-mail:	yangyingmei@lianluo.com

 

with a copy (which shall not constitute notice) to:

 

Jin & Koppell PLLC

99 Park Avenue, Suite 1100

New York, NY 10016

	 	Attention:	Ruth Jin
	 	E-mail:	rjin@jinlex.com

 

		(iv)	if to the Minority Representative, to

 

Fred Chang

1260 Dorothea Rd.

La Habra Heights, CA 90631

E-mail: fred.the.chang@gmail.com

 

with a copy (which shall not constitute notice) to:

 

Lee Cheng

Maschoff Brennan

100 Spectrum Center Dr., Suite 100

Irvine, CA 92618

Email: lcheng@mabr.com

 

All such notices, requests, demands, waivers
and other communications will be deemed to have been received (w) if by personal delivery, on the day of such delivery, (x) if
by certified or registered mail, on the fifth Business Day after the mailing thereof, (y) if by next-Business Day or overnight
mail or delivery, on the day delivered or (z) if by email prior to 5:00 p.m. at the place of receipt, on the day on which
such email was sent, provided that a copy is also sent by certified or registered mail.

 

Section 5.08
Reorganizations. Nothing in this Agreement shall prevent the Company from effecting, and the Parties to this Agreement
hereby authorize the Company or any of its Subsidiaries with the approval of the Board to effect, any recapitalization, corporate
reorganization, “corporate inversion” involving the creation of one or more holding companies and/or holding company
subsidiaries, or similar transaction (any such transaction, a “Reorganization”). The provisions of this Agreement
shall apply, to the full extent set forth herein, with respect to any Company Shares or other Equity Interests of the Company
or any of its Subsidiaries, or any successor or assign of the Company (whether by merger, consolidation, sale of assets, business
combination or otherwise) that may be issued in respect of, in exchange for, or in substitution of such Company Shares and shall
be appropriately adjusted for any share dividends, splits, reverse splits, combinations, recapitalizations, and the like occurring
after the date hereof. If the Board approves any such Reorganization, each Principal Shareholder agrees to consent to and raise
no objection to such Reorganization, and to take all actions determined by the Board to be necessary and appropriate in connection
with the consummation of such Reorganization.

 

    - 11 -

     

    

 

Section 5.09
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an
original and all of which together shall be deemed to constitute one and the same agreement. This Agreement may be executed by
facsimile or electronic transmission in portable document format (.pdf), each of which shall be deemed an original.

 

Section 5.10
Severability. In the event that any one or more of the provisions contained herein, or the application thereof in
any circumstances, is held invalid, illegal, or unenforceable in any respect for any reason, the validity, legality, and enforceability
of any such provision in every other respect and of the remaining provisions contained herein shall not be in any way impaired
thereby.

 

Section 5.11
Amendment and Waiver. This Agreement may be amended, and the observance of any term of this Agreement may be waived,
with (and only with) the written consent of each of the Company, the Minority Representative and Liaison; provided, however,
that any such amendment that would disproportionately, materially and adversely affect the rights of any other Principal Shareholder
shall not to that extent be effective without the written consent of such other Principal Shareholder. Each Party (including the
Newegg Shareholders) agree to be bound by any amendment or waiver made in compliance with the prior sentence. No waiver of any
breach shall be deemed to be a further or continuing waiver of such breach or a waiver of any other or subsequent breach. Except
as otherwise expressly provided herein, no failure on the part of any Party to exercise, and no delay in exercising, any right,
power or remedy hereunder, or otherwise available in respect hereof at Law or in equity, shall operate as a waiver thereof, nor
shall any single or partial exercise of such right, power or remedy by such Party preclude any other or further exercise thereof,
or the exercise of any other right, power or remedy. Notwithstanding the foregoing, any amendment or modification hereto solely
to add or remove parties to this Agreement as a result of Transfers permitted and in accordance with the terms of this Agreement
shall not require the consent of any party hereto. At any time hereafter, Permitted Transferees may be made Parties in accordance
with the provisions of this Agreement and by executing a signature page in the form attached as Exhibit A hereto, which
signature page shall be countersigned by the Company and shall be attached to this Agreement and become a part hereof without
any further action of any other Party.

 

Section 5.12
Tax Withholding. The Company shall be entitled to require payment in cash or deduction from other amount payable
to any Principal Shareholder of any sums required by federal, state, or local tax Law to be withheld with respect to the issuance,
vesting, exercise, repurchase, or cancellation of any Company Shares or any option to purchase any Company Shares.

 

Section 5.13
Entire Agreement. This Agreement, together with any executed Joinders, constitutes the entire agreement of the Parties
with respect to the subject matter hereof.

 

    - 12 -

     

    

 

Section 5.14
Legends. To the extent the Company Shares are certificated at any time, each certificate representing Company Shares
from time to time owned by the Principal Shareholders shall bear a legend substantially as follows:

 

“THE SHARES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO A RIGHT OF FIRST REFUSAL AND OTHER RESTRICTIONS. THESE SHARES SHALL NOT BE TRANSFERRED EXCEPT
IN ACCORDANCE WITH THAT CERTAIN SHAREHOLDERS AGREEMENT AMONG THE COMPANY AND CERTAIN OF ITS SHAREHOLDERS.”

 

Article VI.

 

DEFINITIONS

 

Capitalized undefined terms used herein shall have the same
meaning ascribed to them in the amended and restated memorandum and articles of association of the Company. For purposes of this
Agreement, the following terms shall have the respective meanings set forth below:

 

“Affiliate”
means, with respect to any specified Person, any other Person that, at the time of determination, directly or indirectly through
one or more intermediaries, Controls, is Controlled by, or is under common Control with, such specified Person; provided that no
Shareholder shall be deemed an Affiliate of any other Shareholder solely by reason of their investment in the Company.

 

“Board” means
the board of Directors of the Company or the Directors present at a duly convened meeting of the Directors at which a Board Quorum
is present.

 

“Business Day”
means a weekday on which banks are generally open for business in the British Virgin Islands other than a Saturday, Sunday or other
day on which banking institutions in New York, New York or the People’s Republic of China or British Virgin Islands are required
or authorized by Law or executive order to be closed.

 

“Company Shares”
means the Company’s Common Shares (formerly known as Class A Common Shares).

 

“Control”
or “Controlled” means, as for any Person, the possession, directly or indirectly of the power to direct or cause
the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract or
otherwise.

 

“Director”
means those persons holding office as directors of the Company from time to time.

 

“Equity Interests”
means any shares or capital shares of or other type of equity interest in a Person, including any restricted shares, warrants,
options or other securities to purchase capital shares or other types of equity interests.

 

“Exchange Act”
means the Exchange Act of 1934, and the rules and regulations promulgated thereunder.

 

    - 13 -

     

    

 

“Excluded Issuance”
means (i) any Equity Interests issued as share dividends, or pursuant to share splits, recapitalization or other similar events
that do not adversely affect the proportionate amount of the Company Shares held by the Principal Shareholders, (ii) Company Shares
issuable to officers, employees, directors, managers or independent contractors of the Company or any of its Subsidiaries pursuant
to warrants, options, notes or other rights to acquire securities of the Company issued pursuant to any stock option or any similar
equity incentive plan of the Company approved by the Board; and (iii) Equity Interests issued pursuant to acquisitions or strategic
transactions approved by a majority of the disinterested directors of the Company provided that any such issuance shall only be
to a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries, an operating company or an owner
of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in
addition to the investment of funds, but shall not include a transaction in which the Company is issuing Equity Interests primarily
for the purpose of raising capital or to an entity whose primary business is investing in securities.

 

“Fair Market Value”
means the fair market value determined in good faith by the Board.

 

“GAAP” means
United States generally accepted accounting principles.

 

“Governmental Entity”
means any national, federal, provincial, state, county, township, municipal, local or foreign government, or any legislature, administrative
or regulatory authority, agency, commission, board, bureau, branch, department, division, court, tribunal, magistrate, justice,
multi-national organization, quasi-governmental body, or other similar recognized organization, body or instrumentality of any
federal, state, county, township, municipal, local or foreign government or any other similar recognized organization, body or
instrumentality exercising similar powers or authority.

 

“Holder” means
each holder of Locked Up Securities.

 

“Law” means
any law (statutory, common or otherwise), constitution, treaty, convention, statute, ordinance, code, rule, regulation, standard,
judgment, order, writ, injunction, ruling, decree, decision, arbitration award, agency requirement or other similar authority enacted,
adopted, promulgated, entered or applied by any Governmental Entity.

 

“Locked Up Securities”
means all Company Shares held by the Principal Shareholders.

 

“Minority Representative”
means the representative selected by the Newegg Shareholders holding a majority of the total voting interests represented by the
Company Shares held by the Newegg Shareholders, subject to removal and reselection by such Newegg Shareholders from time to time.
The initial Minority Representative shall be Fred Chang.

 

“Percentage Interest”
means, with respect to any Principal Shareholder, the percentage derived by dividing (i) the number of Company Shares owned
by such Principal Shareholder, by (ii) total number of the then outstanding Company Shares held by all Principal Shareholders.

 

“Permitted Transferee”
means any Affiliate Transferee or any Transferee that has received Company Shares from any Principal Shareholder in accordance
with ‎Section 1.03 (Right of First Refusal).

 

    - 14 -

     

    

 

“Person” means
individuals, corporations, trusts, the estates of deceased individuals, partnerships, limited liability companies, unincorporated
associations of persons and other legal entities.

 

“Pro Rata Share”
means for purposes of ‎Section 1.03 (Right of First Refusal), the percentage which corresponds to the ratio which
each ROFR Shareholder’s Percentage Interest bears to the total Percentage Interests of all ROFR Shareholders exercising their
ROFR Right.

 

“Public Offering”
means an offering  of Company Shares pursuant to a registration statement filed with
the SEC where such Company Shares will be listed on the New York Stock Exchange, the NASDAQ Global Market, the NASDAQ Capital Market,
or any other internationally recognized stock exchange.

 

“Representatives”
as to any Person, means such Person’s directors, officers, employees, Affiliates, consultants, financial advisors, financial
sources, attorneys and accountants or agents.

 

“SEC” means
the Securities and Exchange Commission of the United States.

 

“Securities Act”
means the Securities Act of 1933, and the rules and regulations promulgated thereunder.

 

“Subsidiary”
of any specified Person means another Person, 50% or more of the total combined voting power of all classes of Equity Interests
or other voting interests of which, or 50% or more of the Equity Interest of which, is owned directly or indirectly by such
specified Person.

 

“Transfer”
means any direct or indirect sale, bequest, exchange, assignment, gift, transfer, pledge, creation of any security interest or
other encumbrance, and any other disposition of any kind (whether with or without consideration and whether voluntary or involuntary
or by operation of Law) affecting title to or possession of any Company Shares.

 

    - 15 -

     

    

 

EXHIBIT A 

 

FORM OF JOINDER

 

By execution of this joinder, the undersigned
agrees to become a party to, be bound by the obligations of, and receive the benefits of, a Permitted Transferee as defined in
and pursuant to the Newegg Inc. Amended and Restated Shareholders Agreement, dated as of [●], 202[●], by the parties
thereto, as amended from time to time thereafter.

 

	 	 
	 	[Name of Permitted Transferee]
	 	 
	 	Address:
	 	 
	 	 

 

	 	Acknowledged and accepted by:
	 	 	 
	 	Newegg Inc.
	 	 	 
	 	By:	                  
	 	Name: 	 
	 	Title:  	 

 

 

- 1 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]